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ABSTRACT 
Controlled release drug delivery systems are polymeric de-
vices which are implanted at or near the intended site of action for 
the purpose of drug delivery at controlled rates for extended 
periods. In this thesis, various types of drug delivery devices 
including monolithic, reservoir, and combined monolithic-reservoir 
devices were prepared and the release kinetics evaluated as a func-
tion of device design and composition. Emphasis is placed on proges-
terone as a model hydrophobic drug. The hydrogel devices were pre-
pared from hydroxyethyl methacrylate (HEMA) and copolymers of HEMA 
with methoxyethyl methacrylate (MEMA), methoxyethoxyethyl methacrylate 
(MEEMA), or methyl methacrylate (MMA). Hydrogels prepared from chi-
tosan were investigated also. 
Initial work emphasized drug transport studies in hydrogel 
films. For these studies, an equation was developed to describe 
the special case of solute transport under the condition of a high 
membrane-water partition coefficient and low solubility in the per-
meation solvent. Several solute-membrane combinations were investi-
gated which may be summarized as follows: (i) an increase in the 
initiator content leads to a small decrease in progesterone per-
meability coefficients probably due to increased crosslinking of the 
polymers; (ii) estriol permeability coefficients in pHEMA crosslinked 
with ethylene glycol dimethacrylate were smaller than progesterone 
due to a decrease in the solute membrane partition coefficient; 
(iii) progesterone and estriol permeability coefficients decrease with 
increases in weight percent of MMA in copolymers of HEMA and MMA due 
to a decrease in the water content. At high mole fractions of MMA, 
the permeability coefficients are relatively constant suggesting that 
a solution-diffusion mechanism is operative; (iv) partition coeffi-
cients for both estriol and progesterone produce a maximum when 
plotted as function of weight percent MMA. This was interpreted in 
terms of a domain structure for the HEMA-MMA copolymers; and (v) hy-
drogels prepared from chitosan are, in general, more permeable than 
pHEMA for the same solutes, however, chitosan permeabilities were 
found to be sensitive to the charge of the solute due to charge-
charge interactions in the film. 
Existing equations which describe solute release rates from 
cylindrical monolithic devices were evaluated and a new equation 
developed which includes the effects of drug released from the 
planer ends of the device. The conditions under which the release 
from the planer ends can be neglected were developed from the re-
lease data. 
Drug release from cylindrical monolithic hydrogel devices 
containing progesterone were evaluated. It was found that the rate 
of water influx strongly influences the initial release rates. It 
was postulated that the initial release rates should decrease due to 
a crossflow of solute and solvent within the water-filled channels 
or pores of the film. It was found, also that the permeability 
v 
coefficients were dependent upon the initial drug load. This effect 
~as probably due to changes in polymer structure which arise during 
precipitation of the solute. That this effect was not an artifact 
of the release studies was confirmed from transport studies on drug 
depleted films. 
The release of drugs from reservoir and the combined reser-
voir-monolithic devices were, in general, consistent with those ex-
pected based on the transport studies. However, when the swelling 
of the monolithic core material was strongly affected by the barrier 
layer, the release rates were significantly lower than predicted 
values. 
The final portion of this thesis deals with the mechanisms 
of solute permeation in pHEMA-based hydrogels using the methods of 
irreversible thermodynamics. From this study, it was found that 
hydrogels are highly selective membranes. The selectivity is in-
creased by crosslinking. The results of the study emphasize the 
porous nature of solute transport in the films. However, for cer-
tain solutes, transport within and through the polymer segments 
contributes to the total solute permeability. 
vi 
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Chapter 1 
INTRODUCTION 
Recently, the use of polymeric materials for medical pur-
poses has been an intense area of research. Rapid progress in poly-
mer chemistry and modern medical technology has made it possible to 
use polymeric materials for implant devices that would reinforce or 
replace the function and structure of weakened organs and tissues. 
Some examples of such devices are sutures, catheters, blood expanders, 
synthetic cartilages, artificial joints, artificial organs, dental 
devices, contact lenses, and drug delivery systems. 
A great variety of polymers have been studied as candidate 
materials for implant devices. Although the proporties required by 
the polymer will depend upon the specific application, certain gen-
eral properties must be met by all materials. Included among these 
are: (i) the appropriate physical-mechanical properties to achieve 
the desired structural function of the device; (ii) the necessary 
chemical stability to ensure the maintainance of the mechanical 
properties over time; and (iii) the desirable, biocompatability of 
the material. The physical and chemical properties should be re-
tained during prolonged implantation in the rather severe environ-
ment of the body. Hydrolytic stability of the material is required 
since enzymes and body fluids may cause degradation 'of susceptible 
chemical bonds. Adsorption and absorption of biological fluids, 
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which will inevitably occur, should not alter or adversely affect 
the properties of the implanted polymer. Finally, the implanted 
device in contact with the biological system must not contribute to 
deleterious toxicity, tissue reaction, blood clotting, infection, 
allergy, irritation, or carcinogensis. 
Polymers frequently used in medicine include: silicones (1-4), 
acrylic resins (5-7), poly(vinyl chloride), polytetrafloroethylene, 
polyethylene, polypropylene, epoxyresins, polyurethanes(S), poly-
esters (9), polycarbonates, and hydrogels. Of these, the hydrogels 
have attracted attention for applications which require blood and 
tissue biocompatability. 
A hydrogel is defined as a polymeric material capable of 
imbibing large quantities of water (e.g., greater than 20 percent 
by weight) without dissolving. Many polymers of synthetic and na-
tural origin satisfy this definition. For example, synthetic hydro-
gels include poly(hydroxyalkyl methacrylates), poly(vinyl alcohol), 
and crosslinked poly(N-vinyl pyrrolidone). Natural biopolymers such 
as chitosans, dextans, and collagens are also hydrogels. 
Hydrogels have many advantages relative to other synthetic 
polymers for certain biomaterial applications. Some of the advant-
ages are: (i) the soft and rubbery character of a hydrogel, (ii) 
the high permeability to small molecules, and (iii) a good biocom-
patability. The soft and rubbery character affords greater compat-
ability with surrounding tissue by minimizing mechanical irritation. 
Small molecules such as polymerization initiators, decomposition 
products, and unreacted monomer are thought to be the cause of toxic 
3 
inflammation and eventual rejection of implanted biomaterials (10). 
These undesired small molecules can be eliminated from the gel by 
soaking in proper solvents for an appropriate period prior to the 
implantation of the hydrogel in the body_ According to the minimum 
interfacial free energy hypothesis developed by Andrade et ale (11,· 
12, 13), hydrogels may exhibit a high degree of blood and tissue 
biocompatability due to low water-polymer interaction energy_ If 
protein absorption is assumed to decrease as the interfacial free 
energy decreases, a good biomaterial should exhibit the lowest inter-
facial free energy when in contact with biological fluid. For hydro-
gels this value is close to zero whereas most other polymers exhibit 
2 much larger values in interfacial free energy (e.g., > 20 ergs/cm ). 
With respect to this property the hydrogel can be considered a good 
candidate biomaterial. More recently, work by Ratner (14) has sug-
gested that an adequate amount of water present in the polymer is 
necessary rather than merely a ~ water content in the polymer. 
The basis of this hypothesis resides in a consideration of the proper 
"balance of polar and apolar sites ll present at the surface of the 
polymer. Ratner found that approximately equal amounts of polar and 
a polar sites on polymer surface enhanced blood compatability. 
Hydroge1s can be synthesized from various monomers such as 
hydroxya1ky1 methacrylate, acry1amide derivatives, N-vinylpyrro1i-
done, acrylic acid derivatives, and aminoethyl methacrylate. Hydro-
gels also can be formed by the conversion of functional groups from 
other polymers (e.g., poly(vinylalcoho1) from po1y(vinylacetate)). 
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The properties of various hydrogels change depending on the nature 
of the functional groups attached to the polymeric backbone. This 
wide number of possible hydrogel structures results in a correspond-
ingly large number of possible applications of the hydrogels in the 
biomedical field (15-47). Some examples of biomedically important 
hydrogels are: 
1. Poly(acrylamide), poly(methacrylamide), and deri-
atives (48); 
2. Polyelectrolyte complexes (49-51); 
3. Poly(vinylalcohol) (52-56); 
4. Anionic and cationic hydrogels (18, 20, 22, 57, 58); 
5. Poly(N-vinyl-2-pyrrolidone); and 
6. Poly(hydroxyethyl methacrylate), (pHEMA). 
Among these, pHEMA has received special emphasis because 
this polymer is hydrolytically stable, and is generally biocompatible. 
In addition, the water content of this polymer can be controlled 
easily by copolymerization and to some extent by crosslinking. 
Water content is one of the most important properties of a 
hydrogel. As discussed above, much of the rationale for the bio-
compatability of hydrogels revolves around the presence and the 
water content of the polymer. Water content also affect mechani-
cal properties. It is generally found that as the water content 
increases the mechanical strength decreases while the "softness" of 
the hydrogel increases. Water content is important also in the 
control of the solute transport characteristics of hydrogel 
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membranes. Generally, a higher water content leads to an increased 
rate of solute transport (59). 
pHEMA is a hydrogel with a water content of about 40 percent 
by weight. Copolymerization of pHEMA with po1y(methoxyethoxyethy1 
methacrylate), (pMEEMA), will increase the final water content of 
the copolymer whereas copolymerization of pHEMA with either po1y-
(methoxyethy1 methacrylate), (pMEMA), or po1y(methy1 methacrylate), 
(pMMA), will reduce the water content of the copolymer from that of 
pure pHEMA. 
It is, therefore, natural to expect that pHEMA and its vari-
ous copolymerized methacrylate derivatives will exhibit a broad 
range of transport properties which may provide a wider variety of 
potential application such as, soft contact lenses (60), kidney 
dialysis mebranes (45, 61-65), reverse osmosis membranes (61, 66-69), 
and controlled release drug delivery systems. 
In this study, applications of hydrogel for controlled re-
lease drug delivery systems will be specifically discussed. 
Conventional methods of drug delivery such as tablets and 
capsules require periodic administration. As a result of this method 
of administration, 'peaks' and 'valleys' in the drug plasma concen-
tration will be produced (Figure 1.1). These fluctuations in the 
plasma concentration of a drug can result in near toxic or sub-
therapeutic drug levels. On the other hand, frequent application 
of smaller doses, which is thought to 'smooth-out' these fluctuations 
in plasma concentration, will cause inconvenience and a greater 
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Figure 1.1. Schematic plot of drug blood level versus time for 
conventional drug dosage regimen. 
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therapy. Such a failure may result in the lack of effectiveness of 
the drug. 
Because of these problems, related to conventional drug 
administration, recent efforts have been made at new drug administra-
tion techniques which can provide both sustained and controlled re-
lease of pharmacological agents at the desired site of action. Such 
methods of drug delivery are especially suited to drugs which must 
be delivered at constant rates over long periods. Examples of such 
drugs include contraceptive steroids, narcotic antagonists, anti-
hypertensives, and anticonvulsants. 
Polymeric devices can be used to deliver drugs to a specific 
site by implantation at or near the intended site of action. Poly-
meric devices containing a certain amount of drug may be implanted at 
the specific site on or in the body_ Because a drug can permeate 
through a polymer membrane, the drug may be delivered directly to 
the site. Providing that the release rate of drug can be controlled, 
a properly designed device could deliver precise amounts of drug 
to the implantation site for extended periods. Some of the examples 
of localized polymeric drug delivery systems are PROGESTASERT (70) 
and OCUSERT (70). The PROGESTASERT delivers progesterone to the 
uterus for one year while the OCUSERT delivers pilocarpine to the 
eye of the patient for seven days. 
Controlled release drug delivery systems are formulated by 
the combination of the drug and polymer. The polymer membrane con-
trols the release rate of the drug at an optimal level by acting as 
a diffusional barrier for the release of the drug. 
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Many design variations for controlled release drug delivery 
systems have been studied or proposed. Although the shapes or geo-
metries can vary widely, the basic design can be classified as 
monolithic, reservoir, or combined monolithic-reservoir type 
devices. 
Monolithic devices are composed of a drug dispersed within 
a polymer matrix. The polymer may be either biodegradable or non-
biodegradable. The polymer matrix controls the release by control-
ling the diffusion rate of solutes through the matrix or by erosion 
of the matrix. In the latter case it is likely that both erosion 
and diffusion contribute to the total release rate. For the case 
of monolithic hydrogel devices containing highly water soluble 
solutes dispensed in the matrix, an additional release mechanism is 
possible (71). In such systems, large osmotic pressures can be 
generated which act as the major driving force for drug release. 
Release occurs through channels created by osmotic rupture of drug 
containing capsules within the polymer. 
Reservoir type devices consist of a polymeric capsule which 
is filled with an active agent or with a suspension of the drug in 
a fluid medium. In this device, drug release is controlled by 
diffusion through the polymer wall. 
Combined tYDe devices are composed of a core polymer contain-
ing dispersed drug as in the monolithic device. This core is sur-
rounded by a second polymer of lower permeability than the core.poly-
mer. Drug release is controlled mainly by diffusion through the 
second polymer. 
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In order to design a controlled release system, many factors 
shoul d be considered. Some of them are as follows: (i) optimum 
therapeutic level of the active agent, (ii) membrane biocompatabil-
ity with the biological environment, (iii) physiochemical stability 
of a membrane in the environment, (iv) reactivity of active agents 
with the polymer, (v) kinetics and transport mechanisms of the ac-
tive agent from the polymeric system, and (vi) influence of the 
biological environment on the transport mechanism and kinetics. 
In this research, the potential of hydrogels as biomedically 
applied materials for controlled release drug delivery systems is 
evaluated. The kinetics and mechanisms of drug permeation through 
hydrogel films are studied. Drug release from three types of drug 
delivery systems are presented. In Vitro release data from such de-
vices can be interpreted based on the data obtained in this study 
together with data reported in the literature. Chapter 2 describes 
experimental procedures. In Chapter 3, transport phenomena for 
steroids through various hydrogels is described to obtain diffusion 
data needed for the design of contraceptive drug delivery systems. 
Permeation studies of nonsteroidal solutes such as urea, glucose, 
and sucrose are studied also to better understand general solute 
permeation phenomena. Poly (hydroxyethyl methacrylate) containing 
various amounts of ethylene glycol dimethacrylate as a crosslinking 
agent is used in the hydrogel membranes. Copolymers of hydroxyethyl 
methacryl ate and methyl methacryl ate are a 1 so used to regul ate perme-
ability. Chitosan is used as a membrane material to further 
study solute-polymer interactions. Progesterone release from 
10 
monolithic, reservoir, and combined devices is described in Chapters 
4 and 5. The experimental release rates from these devices are com-
pared with predicted values based on theories found in the litera-
ture. Dependence of the drug release rate on device geometry is 
studied. An irreversible thermodynamic approach of analyzing dif-
fusion phenomena is presented in Chapter 6 to obtain more detailed 
information concerning solute diffusion which cannot be obtained by 
classical methods of analysis. Chapter 7 provides a summary and 




Silastic elastomer (Medical grade 382) and DOW CORNING Cata-
lyst M. (Dow Corning Corporation, Monrovia, California) were used as 
received. The elastomer has a filler of unknown concentration. 
Hydroxyethyl methacrylate (HEMA; courtesy of Hydron Labora-
tories, New Brunswick, New Jersey), was a highly purified sample and 
was used as received. A typical analysis of impurities as determined 
by Hydron Laboratories is 
Methacry1ic acid 









Methoxyethoxyethyl methacrylate (MEEMA) was prepared by the 
following method: To a 2 1 round bottom flask equipped with thermo-
meter, Dean-Stark trap, magnetic stirrer and heating mantle were ad-
ded methacrylic acid (225 ml, 260 g), methoxyethoxyethanol (427 m1), 
10 g hydroquinone monomethylether, 2 9 p-toluenesulfonic acid, and 
400 m1 benzene. The flask was heated to reflux and water was removed 
as a benzene azeotrope using a Dean-Stark trap_ After no more water 
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was collected, approximately 75 percent theoretical, the reaction 
mixture was allowed to cool. The reaction mixture was extracted 
with 5 percent NaOH solution to remove unreacted methacrylic acid, 
p-toluenesulfonic acid and hydroquinone monomethyl ether. After 
three extractions the organic phase was dried over anhydrous magnesium 
sulfate and the solvent was removed under reduced pressure. The re-
sulting material was then vacuum distilled to yield MEEMA. The center 
cut of the distillate (B.P 65-70 DC at 1 mm Hp) was used for further 
study. 
MEMA \.>/as synthes i zed in the same manner. (The above procedure 
for the preparation was kindly provided by Dr. D. E. Gregonis of the 
Department of Materials, Science and Engineering, The University of 
Utah. ) 
Ethyleneglycol dimethacrylate (EGDMA, Monomer Polymer Labora-
tories, Philadelphia, Pennsylvania), was purified by base extraction 
to remove inhibitor followed by distillation. Azobis (methy1isobuty-
rate), prepared by the method of Mortimer (72), was used as initiator. 
Chitosan was prepared by the method of Brossignac (73) where 
a deacety1ation reaction using base treatment of chitin (poly-N-
acetyl glucoasamine; practical grade, SIGMA Chemical Company, St. 
Louis, Missouri), was used. Specifically, 20 gms of chitin was re-
fluxed under a nitrogen atmosphere in 150 ml of 3.5% NaOH solution 
for one hour. The mixture was filtered hot and was washed until 
neutral with distilled water, then with 95 percent ethyl alcohol, and 
finally, diethyl ether. The solid was dried i vacuuo for one hour 
at 45°C. 
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The deproteinized chitin was then refluxed under nitrogen 
atmosphere in mixed solution system which contains 67 g ethyleneglycol, 
67 9 95 percent ethyl alcohol, 5 ml distilled water, and 134 g KOH. 
After 20 hours the yellow mixture was diluted with 200 ml ethyl alco-
hol and filtered hot. The filtrate was washed with distilled water 
until neutral and then with ethyl alcohol and diethyl ether. The 
filtrate was dried in vacuuo for 90 minutes at 45 - 50°C. The final 
product was approximately 13 g of white solid 
Progesterone, estriol (Stera10ids, Inc., Wilton, New Hampshire), 
sodium methotrexate (lederle Parenterals, Inc., Carolina, Puerto Rico 
00630), cocaine hydrochloride (USP grade Merck & Co., Inc., Rahway, 
New Jersey), [1,2 - 3HJ progesterone, [benzoyl - 3,4 - 3HJ cocaine 
hydrochloride, [14CJ urea, [14CJ sucrose, [3HJ water (New England Nu-
I I 3 
clear, Boston, Massachusetts), sodium [3 , 5 , 7 - HJ methotrexate 
and [2,4,6,9 - 3HJ estriol (Amersham, Arlington Heights, Illinois) 
were used as received. Thin layer chromatographic analysis of the 
steroids showed that these of compounds are pure. Urea, glucose, 
and sucrose were reagent orade purity and recrystallized 
either from ethyl alcohol or water. 
2.2 Methods 
2.2.1 Membrane Transport Experiments 
Hydrogel membranes from methacrylate derivatives were syn-
thesized by free radical polymerization. Azobis (methylisobutylate) 
was used to initate polymerization at a concentration of 7.8 m mole/ 
liter monomer. The mixture of monomer and initiator was polymerized 
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between two high density polyethylene plates at 60°C for 24 hours. 
After polymerization, the membrane was soaked in deionized distilled 
water for at least seven days. Water was replaced every day to 
eliminate impurities such as unreacted monomer. 
Chitosan membranes were prepared by a solvent casting method. 
Chitosan was converted to the perchlorate salt. The salt formation 
procedure is as follows: 2.5 g of chitosan was added to 80 ml of 
distilled water which was stirred by magnetic stirring bar. Seventy 
percent HC10 4 was added dropwise until most of the solid was dissolved. 
The pH of the solution was maintained at approximately 5.0 to avoid 
hydrolysis. The viscous solution was centrifuged for 15 minutes at 
5,000 rpm and then decanted. The solution was freeze dried to give 
a white solid of chitosan perchlorate. 
To prepare chitosan membranes the perchlorate salt was dis-
solved in distilled water. This solution was cast in a plastic petri 
dish and evaporated to give a thin membrane. This membrane was soaked 
in 10 percent ammonium hydroxide solution to convert the perchlorate 
salt to the neutral chitosan. This membrane was placed in water for 
at least seven days. Water was replaced every day to eliminate im-
purities. (The above procedure for the preparation of chitosan film 
was kindly provided by Dr. C. G. Anderson of this laboratory.) 
A glass diffusion cell ~ which contains two compartments of 
equal volume (175 ml), Figure 2.1, was utilized in diffusion experi-
ments. The membrane was clamped between two compartments of equal 
'volume. In order to minimize boundary layer effects each compartment 












gure 2.1. Schematic diagram of diffusion cell used in membrane 
transport studies. 
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externally mounted to a constant speed synchronous motor. 
At the beginning of each experiment, one compartment was 
filled with a solution containing both labeled and unlabeled solute. 
The other was filled with nonradioactive solution of the same solute 
or with distilled water. The concentrations of solute in both cham-
bers were measured by withdrawing approximately 150 ~l of sample in 
duplicate at various times. The samples were weighed in tared vials, 
10 ml of scintillation fluid (Formula 950A, New England Nuclear, 
Boston, Massachusetts) was added and the sample was counted in a 
Packard Scintillation Counter. In some experiments solute concentra-
tions were measured by both UV spectroscopy and scintilation count-
ing. Both methods gave the same result in the limit of experimental 
error (usually plus minus 10 percent error). The thickness of the 
wet membrane was measured using a light micrometer (Van Keuren Com-
pany) . 
The water content of the hydrogel membrane (Wf) was determined 
using the following equation: 
Wf = (Wo - Wd)/Wo (2 -1 ) 
where Wo and Wd are the weight of the hydrated gel and weight of the 
nonhydrated membrane, respectively. 
Partition coefficients (Kd), defined as the ratio of the con-
centrations in the gel and in the aqueous phase, were determined by 
a solution depletion technique (74) in which the aqueous solution was 
allowed to equilibrate with a hydrogel membrane. The following equa-
tion was used: 
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Kd = Vw Vm 
Co - Ce (2-2) 
Where Vw is the volume of water, Vm is the volume of membrane, and 
Co and Ce are the initial and equilibrium solute concentrations, 
respectively. 
2.2.2 Release from Monolithic Devices 
2.2.2.1 Progesterone release from silastic devices. A mix-
ture of labeled and unlabeled progesterone was made by dissolving the 
steroids in ethanol and evaporating the solvent. This mixed drug 
together with 0.125% of catalyst by weight was added to the silicone 
polymer. A mortar and pestle was utilized to achieve a good disper-
sion of these constituents. The mixture thus obtained was placed in 
a high density polyethylene mold and allowed to cure. These rods 
were cut to give three different values of the ratio of radius to 
height of the device. Each of these rod shaped devices was immersed 
in all beaker containing 900 ml of distilled deionized water. 
The devices were supported in the cell via metallic holders made from 
nickel-chrome wire. The aqueous phase was constantly agitated by a 
stirrer at 1600 rpm. The eluting fluid was totally replaced at each 
sampling period, which was usually every hour in root time for three 
days and every day thereafter. All experiments were performed 
at room temperature (23 ! 1°C). Sampling was continued until more 
than 90% of drug was released. The concentrations of the solutions 
were measured by scintillation counting. A sample volume of 0.5 
ml was used. 
18 
In order to evaluate the release rate from these devices, 
the aqueous solubility of progesterone is required. This value was 
determined using three methods. In the first, a rod-shaped hydrogel 
matrix device containing labeled and unlabeled drug was placed in 
an aqueous solution in a covered beaker. The aqueous phase was 
stirred continuously and the concentration was checked until a con-
stant value was reached. The second method was similar to the first, 
except that several rod shaped hydrogel devices containing both 
labeled and unlabeled drug were placed in an open beaker. The aqueous 
phase was stirred continuously. Over time, the volume of the aque-
ous phase decreased. The aqueous phase concentration was monitored 
until a steady state value was reached. At this time, the aqueous 
phase was passed through a glass membrane filter until successive 
portions produced the same value. In the third method, excess solid 
progesterone was added to a beaker containing approximately one 
liter of water. This solution was sonified for approximately six 
hours. The solution was allowed to cool and was then left undis-
turbed for two days. The supernatant was filtered through a glass 
filter, and the concentration was determined by UV spectroscopy. 
2.2.2.2 Progesterone release from monolithic hydrogel 
devices. Rod shaped monolithic hydrogel devices were prepared in a 
polyethylene mold by polymerization at 60°C for 24 hours. Azobis 
(methy1isbutyrate) at a concentration of 7.84 m moles/liter of 
monomer was used as the initiator. Prior to polymerization, a mix-
ture of labeled and unlabeled progesterone was dissolved in the 
monomer to obtain a homogeneous solution. The maximum concentra-
tions utilized approximate the saturation solubility of drug in 
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monomer. The dimensions of the dried devices used in the experiments 
were approximately 4 cm (height) by approximately 0.5 cm (diameter). 
Planer monolithic hydrogel devices were prepared using similar tech-
niques except only unlabeled drug was utilized. The thickness of 
these dried films was approximately 0.03 cm. 
Progesterone release studies on the rod shaped devices were 
performed by the same method as in silastic device case. 
The amount of water taken up was determined over time on rod 
shaped devices prepared in an analogous fashion (without labeled 
drug). Excess surface water was removed with tissue paper prior to 
weighing. Percent of water uptake (Wp) was defined as: 
Wp = Wh - Wo x 100 Wo (2-3) 
Where Wh and Wo are the weight of hydrated device and the weight of 
initial dry device. 
Permeability coefficients were determined on the planner de-
vices using the diffusion cell (Figure 2.1) by the same method des-
cribed in Section 2.2.2.1. In this case, the films were depleted of 
the initial drug load by placing the films in a large volume of 
water prior to this experiment. The aqueous phase was stirred con-
tinuously and exchanged every day till the drug is completely de-. 
pleted. The release of drug was followed by UV spectroscopy. Film 
thicknesses, partition coefficients, and water contents of the hy-
drated films were determined as described previously. 
2.2.3 Release of Progesterone from 
Reservoir and Combined 
Type Devices 
2.2.3.1 Drug release from reservoir devices. Rod-shaped 
hydrogel devices which did not contain progesterone were prepared 
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in a polyethylene mold by polymerization of monomers by the method 
described previously. The dimensions of these hydrogel rods were 
approximately 4 cm (height) by 0.5 cm (diameter). A reservoir was 
created by drilling out the central portion of these rods with a 
drill and a 1/8" bit. The central reservoir was filled with ap-
proximately 100 mg of a mixture of labeled and unlabeled progesterone 
in silicone oil. The tops of these devices were sealed by layering 
monomer over the silicone oil and polymerizing. 
Progesterone release studies on the rod-shaped devices were 
performed by the method described in Section 2.2.2.1. The thickness 
of the membrane barriers of the devices together with the diameters 
were determined subsequent to the release studies by light micro-
scopy. 
2.2.3.2 Drug release from combined type devices. Hydrogel 
capsules were prepared as described in the previous section. The 
central hole was filled with a monomer solution containing a mixture 
of labeled and unlabeled steroid. This central mixture was poly-
merized and the top of the device was then sealed as described. 
Progesterone release from this combined type device was per-
formed in the manner described in Section 2.2.2.1. 




pHEMA films with and without one mole percent crosslinker 
(EGDMA) were obtained as described in Section 2.2.2.1. Permeability 
coefficients of solutes in these membranes were taken from the work 
of Wisniewski (59). The water contents in terms of volume fractions 
were obtained from 
~~ vf = d· \~f (2-4) 
Where d is density (obtained from the weight of a disk-shaped mem-
brane of known volume which had been equilibrated with an aqueous 
solution of the solute at a concentration of 0.15 M) and Wf is the 
water content (by weight). Water content (Wf), permeability, and 
partition coefficients were obtained as described in Section 2.2.2.1. 
The partial molal volumes for aqueous urea were evaluated from the 
data of Gucker et al. (75). The values for glucose and sucrose were 
taken from Fri tzi nger et a 1. (76). 
Volume flow was determined in cell (Figure 2.2) similar to 
that described by Fritzinger et al. (76) suitably modified to permit 
temperature control via an external circulatory water bath. It was 
constructed from two No. 25 O-ring joints, 2.5 cm IO. The left com-
partment has a volume of 65 m1 while the right has a volume of 60 m1. 
The membrane surface area was 7.54 cm 2. Vigorous stirring was in-
duced by externally driven magnetic stirring bars. Volume flow was 
determined by measuring the change in liquid height in the capillary 






Figure 2.2. Cell for determining total volume flow. 
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In the determination of the'filt~ation coefficients, the 
volume flow was measured at zero osmotic pressure difference, i.e., 
solute concentrations were the same in both chambers (0. 15M). A 
constant hydrostatic pressure was maintained across the membrane by 
the large reservoir of solution. 
In the determination of the reflection coefficients, the 
volume flow as measured with an osmotic pressure gradient and a 
constant hydrostatic pressure (150 cm Hq). Initially, a 0.15 M 
solution was present in right chamber and distilled water was present 
in left chamber and reservoir. 
Chapter 3 
SOLUTE DIFFUSION ACROSS HYDROGEL MEMBRANES 
3.1. Introduction 
Deternination of permeability parameters of drugs in polymer 
membranes is essential information for the design of controlled re-
lease drug delivery systems. In addition, valuable insight into the 
transport process can be gained based upon mechanistic interpreta-
tions of drug permeation data. In this chapter, permeation data on 
several solutes in various hydroge1s are discussed. The effects of 
initiator, crosslinker, and functional groups are studied. A new 
equation for transport studies in polymeric films, where partition 
coefficients are large, is derived and compared with results ob-
tained from previous equations. A mechanistic interpretation of the 
permeation data is provided for the transport of solutes in pHEMA. 
3.2.1 Derivation of Equations 
Diffusion is mass transport which occurs if a concentration 
gradient is present. This transport occurs as a result of the ran-
dom thermal motions of molecules. In the presence of other molecules, 
an individual molecule will take a random step through the container 
owing to collisions with other molecules or with the walls of the 
container. As time passes, it would be expected intuitively that 
a net flow of molecules from concentrated solution to more dilute 
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solut~on will occur. The rate of transport should be proportional 
to the concentration gradient, the distance between points of obser-
vation, and the area through which transport occurs. The relation-
ship between these variables is know as Fick's Law: 
F1 ux = J dm = = dt 
DA dc 
dl (3 -1 ) 
Where m is the mass of material transfered, t is the time, 1 is the 
distance in the direction in which diffusion occurs, A is the area 
of the plane through which the transfer is made, and D is a propor-
tionality coefficient known as the diffusion coefficient. 
Usually, the diffisuion coefficient is a function of concen-
tration because molecular thermal motion is dependent upon frictional 
forces which are a function of concentration. However, in dilute 
solution, the frictional force between solute and solvent can be 
assumed constant since most col1isons of a solute molecule are with 
surrounding solvent molecules. Therefore, the diffusion coefficient 
should be independent of concentration when the concentration of 
so 1 ute is low. 
In the case of a solution/membrane/solution type of dif-
fusion system, the concept of partition is important. When there is 
a solvent, a membrane, and one kind of solute, the solute will distri-
bute between membrane and solvent until its activity is the same in 
both phases. Because of differing interactions with the phases, the 
solute concentration in the phases at the same activity may be dif-
ferent. The ratio of solute concentration at equilibrium is called 
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the partition coefficient. The partition coefficient, Kd, is de-
fined as: 
Kd = Solute Concentration Within the Polymer Membrane (3-2) 
Solute Concentration in the External Aqueous Phase 
The partition coefficient is, in general, dependent on solute concen-
tration (77). However, for the present study, it is assumed that Kd 
is constant in the range of experimental concentration. This assump-
tion will be verified in Section 3.2.2. 
Figure 3.1 is a diagram showing the distribution of a solute 
in a solution/membrane/solution system in which a concentration 
gradient exists. In such systems, it is generally assumed that the 
concentration gradient in the membrane is linear. 
In order to determine a diffusion coefficient for a solute in 
such a system, it is necessary to develop appropriate solutions to 
Fick's Law. The final equations developed are dependent upon the 
specific conditions under which the experiment is carried out. In 
the present work, equations will be developed for the condition of 
very low aqueous phase concentrations and high membrane-water parti-
tion coefficients. Fick's Law can be applied in a membrane. 
J = _ DA (dCm ) dl (3-3) 
where Cm is the solute concentration in the membrane. During steady 
state, it is assumed that a linear concentration gradient exists in 
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Figure 3.1. Schematic representation of the concentration gradient 
across a membrane. 
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dCm Co - Cl 
- . dx . = (3 -4) 
where Co and C, are the respective surface concentrations of the 
membrane. Substitution of Equation 3-4 into Equation 3-3 gives: 
J = DA Co - C1 (3 -5) 
If the partition coefficient, Kd, is constant in the range of experi-
mental concentration, Equation 3.1 can be expressed as: 
J (3 -6) 
where Co and DR are the respective solute concentrations of donor 
phase and receptor phase, and Kd is defined as: 
(3 -7) 
Mass balance between the donor and receptor phases during steady 
state gives: 
J = (3 -8) 
and 
J = (3-9) 
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Where Vo and VR are the volume of doner phase and receptor phase, 
respectively. Rearrangement and addition of Equations 3-8 and 3-9 
gives: 
(_1 + _1 ) J dt 
Vo VR 
(3-10) 
Equation 3-10 and Equation 3-6 can be combined to give the fo11ow-
ing: 
OAKd (_1 + _1 ) dt 
1 Vo VR 
( 3- 11 ) 
Integration of Equation 3-11 gives: 
(3-12) 
where C1 is integration constant. C1 can be obtained using the 
boundary conditions. If COl and CR1 are the respective concentrations 
of doner and receptor phases at the time (t1) during steady state, 
then C1 can be expressed as: 
C1 = 1n (COl - CR1 ) + ( __ 1 + __ 1 ) OAKd t Vo VR 1 1 
(3-l3) 
Equation 3-13 can be substituted into Equation 3-12 to give: 
( __ 1 + __ , ) OAKd (t _ t ) 
Vo VR ' 
(3-14) 
When the phase volumes are equal, Equation 3-14 can be expressed 
as fo 11 ows: 
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Where V is the volume of either phase. Equations 3-14 and 3-15 
are valid under the condition of steady state and constant partition 
coefficient in the range of experimental concentrations. 
These equations can be simplified further under the special 
conditions which follow: 
1. The amount of solute in the membrane is negligible 
compared with total solute amount. 
2. Steady state is reached essentially at the onset of 
the experiment. 
3. Initially, no solute is present in the receptor 
phase. 
Under the above conditions, tl can be taken as zero when the 
doner phase concentration is zero. Therefore, Equation 3-14 can 
be written as: 
= 
20AKd 
Vl t (3-16) 
where Co is the initial solute concentration in doner phase. The 
amount of solute in the receptor phase, CRV, should be the amount of 
solute leaving the doner phase, CoV - COV. This gives the following 
equation: 






This equation is valid under the conditions of a steady-state flux 
in the membrane and a low membrane-water partition coefficient (78). 
Equation 3-15 can be modified to more clearly demonstrate 
the role of solute partitioning in the membrane in controlling the 
transport process. 
Mass balance at steady state gives 
(COl + CR1 ) V + e V m m (3-19) 
( 3 -20) 
Where COo and eRo are the initial concentrations of solute in donor 
and receptor compartment and e is the average solute concentration 
m 
wi thi n the membrane whose vo 1 ume is V . 
m 
Provided that the concentration gradient in the membrane is 
linear, the average solute concentration in the membrane, e , can 
m 
be expressed as: 
C 
m = 
Kd (COl + CR1 ) 
2 = (3-21) 
Substitution of Equation 3-21 into Equations 3-19 and 3-20 
gives, after rearrangement: 
2V 
= 2V + KdVm 
and 
Equations 3-22 and 3-23 can be substituted into Equation 3-15 
to eliminate COl and CD terms as: 







Equation 3-24 reduces to Equation 3-18 in the limit that 
Kd is small. When the term KdVm/V, is not negligible, it is apparent 
that 0 values ca1cu1ated by Equation 3-18 will be in error. 
Diffusion coefficients can be obtained either by Equation 
3-15 or Equation 3-24. The use of Equation 3-24 is relatively 
simple because it requires that the concentration variation with time 
in only one compartment must be determined. However, this equation 
demands an accurate knowledge of total membrane volume. In the pre-
sent study, i~ is difficult to obtain this value accurately due to 
the lateral diffusion of solute in the membrane. Because of this, 
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the membrane volume is not a simple function of the diffusion cell 
geometry. For this reason, Equation 3-15 is preferred for the de-
termination of membrance diffusion coefficients. 
In studies of membrane diffusion phenomena, the permeability 
coefficient is frequently utilized to describe the flux of solute 
from the donor solution to the receptor solution. The permeability 
coefficient (P) can be defined as the product of membrane diffusion 
coefficient and membrane-water partition coefficient. 
P = Kd x D ( 3- 25 ) 
Equation 3-25 can be substituted into Equation 3-15 to give the 
following equation: 
(3-26) 
CD - CR P is obtained from a plot of ln ( ) versus (t - t l ). From COl - CRl 2AP the known values of A, V, 1, and the slope which is - ~,per-
meabil ity is calculated. 
3.2.2 The Nature of Diffusion and the 
Validity of the Derived Equa-
tions 
As previously stated, the driving force of diffusion is a 
concentration gradient. Flow arises from the random thermal motions 
of individual molecules. This random thermal motion produces a net 
flow of molecules from areas of high concentration to areas of low 
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concentration. However, if we could view this phenomena on the 
microscopic scale and follow the motion of any given molecule, there 
would be an equal chance that this molecule would move from areas of 
low concentration to high concentration. This result is a conse-
quence of the fundamental nature of diffusion. This point was veri-
fied by the following experiments: 
The size and chemical properties of the radiolabeled pro-
gesterone is almost identical to those of unlabeled progesterone. 
Therefore, the transport properties of radiolabeled progesterone is 
expected to be almost the same as those of unlabeled progesterone. 
The permeating properties of labeled and unlabeled progesterone were 
initially confirmed. In one experiment, a progesterone solution of 
10 ~gm/ml was present on the left side of the membrane, while pure 
water was present on the right side. A small amount of radiolabeled 
progesterone was added to the left side. The transport of both 
radiolabled and unlabeled progesterone were measured by radioactivity 
and by UV, respectively. As shown by the data in Table 3.1, both 
experiments yield the same permeation coefficient. This implies that 
radiolabeled progesterone permeates with same rate as unlabeled 
progesterone. Based on this finding, labeled progesterone was treated 
identical to unlabeled progesterone for the permeation study. 
The movement of molecules from a lower concentration to a 
higher concentration was also confirmed. In the next experiment, a 
progesterone solution of 10 ~gm/ml was present on the left side of a 
membrane. On the right side, a progesterone solution of l~gm/ml 
containing a trace amount of radiolabeled progesterone was present 
3S 
Table 3.1. Solute Permeation Coefficients in pHEMA: Concentration 
Effects on Diffusion Coefficients 
Concentration On P x 10 







1 01l9/m 1 0 (by uv) 
1.1 1l9/m1* 0 
1 01l9/m 1 11lg/m1* 
O. lS~1* 0 
O.lSM 0 (by refracto-
meter) 
O.OSM* 0 
O.lSM 0.01 ~1* 

















initially. The concentration changes of both radiolabeled and un-
labeled progesterone over time were measured by the use of scintilla-
tion counter and UV spectroscopy, respectively. It was found that 
the concentration of radiolabeled progesterone in left chamber in-
creases, while that of unlabeled progesterone in same chamber de-
creases. Moreover, the calculated value of the permeation coefficient 
of a radioactive isotop~ whose net flow is from right to left, was 
close to a nonradioactive isotope provided net flow is from left to 
right. If only concentration gradient cause solute transport, there 
should be no drug permeation from right side to left side. 
Data shown in Table 3.1 also justifies the assumption of a 
constant partition coefficient during an experiment for the systems 
used in this study. The concentration of a nonradiactive solute, 
which moves from left to right, is tens of thousands of times greater 
than that of the radioactive solute which moves from right to left. 
If the partition coefficient were to have changed with respect to the 
solute concentration in this experiment, the permeation coefficients 
of both isotopes would have been found to be quite different. The 
results of this experiment indicate that at the low concentration 
used « 12 ~gm/ml for steroids and < .15 M for urea and sucrose) 
there was a constant partition coefficient in the solute-hydrogel 
system during the course of the experiment. Since steady state con-
ditions and a constant partition coefficient were assumed in Equation 
3-15. the use of this equation is quite reasonable using the dif-
fusion cells shown in Figure 2.1. 
3.3.1 Mechanisms of Solute Transport 
Through Hydrogel Membranes 
In order to explain various phenomena of solute transport 
through a polymer membrane, two mechanisms have been suggested. 
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These are: The pore mechanism in which the solute molecules are 
transported through aqueous (solvent filled) micro channels (pores) 
within the membrane; and, the partition mechanism which involves 
solute dissolution within the polymer membrane and consequent diffu-
sion of the solute along and among the polymer chains. 
Good examples of these two mechanisms were found in the work 
of Lyman (79). This author has shown that solute permeation through 
cellophane, which is thought devoid of any charge or absorption 
properties, follows the pore mechanism. This conclusion was based 
on the observation that linear relationship existed between solute 
molecular weight and half-time rate of transfer of many different 
types of solutes. Craig's work (80) has shown the more basic nature 
of the pore mechanism. When a cellophane membrane was stretched in 
a biaxial manner, the pore size of membrane increased and the per-
meability of ribonuclease increased. However, if the membrane was 
stretched in one direction only, the pores change from a circular to 
an eliptical shape, and thus, reduces the effective diameter of the 
passage, reducing the permeability of the solute. Thus, in the pore 
mechanism, the solute passes through micro holes or channels and 
the permeability is directly related to the molecular volume of the 
diffusing solute. 
In contrast, Lyman (79) has shown that the permeabilities of 
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various solutes through block copolymers, based on polyoxyethylene 
glycol and polyethylene terephthalate, demonstrate no clear cut rela-
tionship between molecular weight and half-time rates of transfer. 
This author also studied the effect of temperature on the dialysis 
of urea through the copolymer-ester membrane and concluded that the 
membranes did not act as sieves. This phenomenon may be explained by 
the partition mechanism where the solute dissolves in the membrane 
and diffuses through it. In the partition mechanism, membrane solu-
bility is one of the factors which controls solute permeability. 
Because of differences in membrane solubility, solute transport can-
not be explained by solute size alone. 
For solute transport in hydrogel films, Yasuda et al. (61, 
81-83) developed a model for transport based on the free volume ap-
proach. It was proposed that a homogeneous polymer membrane, in the 
nonhydrated state, is packed uniformly with randomly coiled macromole-
cules leaving unoccupied space as free volume. In the hydrated state, 
an additional contribution to the total free volume of the polymer 
will arise from the free volume within this water phase. It was 
proposed that solute transport within these films is restricted to 
diffusion within the total free volume of the polymer. Based on 
this model, these authors developed the following equations which 
describe the transport of a solute in a hydrated polymer membrane. 
The diffusion coefficient for the solute in the membrane can 
be described by: 
o = v¢(q) exp (- Bq/Vf ) exp (- E/kT) (3-27) 
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Where 0 is the diffusion coefficient, v is the translational oscilla-
ting frequency of the diffusing molecule, ¢(q) is the probability that 
a solute will find at its location a hole of cross-sectional radius 
q which is sufficiently large for the passage of the solute, B is a 
proportionality constant~ Vf is the total free volume of the poly-
mer, E, k, and T have their usual meanings. In an analogous fashion, 
the solute diffusion coefficient in water, Do, can be described by: 
Do = vexp (- Bq/Vf,o) exp (- E/kT) (3-28) 
where Vf , is the free volume in the water. The total free volume of 
the polymer can be defined by: 
(3-29) 
where H is the volume fraction of water in the polymer (i.e., the 
partition coefficient of water between the membrane and water) and 
Vf,l ' is the free volume of the polymer in the dry state. If it is as-
sumed that solute transport occurs only within the aqueous filled 
channels, then Vf = HVf,o and Equations 3-28 and 3-29 can be combined 
to provide that: 
D 1 0- = ¢(q) exp [- B(q/V ) (-H - l)J 
o v,O (3-30) 
According to this equation, a plot of In(D/Do) versus (l/H-l) should 
be linear. Agreement of experimental data with such a plot would sug-
gest that solute transport occurs primarily within the aqueous filled 
channels or pores of the polymer film. 
For the case of water transport in hydrated polymers, Yasuda, 
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Lamaze, and Peter1in (82) developed a similar theory based on the 
free volume approach. For water, these authors assumed that trans-
port can occur within the total free volume of the polymer, that is, 
transport is not restricted to the water p1ase. For this case, the 
final equation may be expressed by: 
-1 
(1 n ~o) 1 -1 -'s (r=-1 -_ o.-r) X S(l-o.) (3- 31 ) 
where X = (1 - H)/H, a = Vf,l/Vf,o' and S = V*/Vf,o • V* is a char-
acteristic volume parameter which can be considered to be the product 
of the cross-sectional radius of the diffusing molecule and the diffu-
siona1 jump distance. Equation 3-31 should be applicable to any 
solute which transports the membrane by diffusion within the total 
free volume of the polymer. 
In principle, it should be possible to discuss the mechanism 
of solute transport in hydrated polymer films by an application of 
both Equations 3-30 and 3-31 to the solute permation data. It is 
expected that all solutes which permeate by diffusion within the free 
volume of both the water and the polymer will follow the behavior 
dictated by Equation 3-31. However, when diffusional data are 
plotted according to Equation 3-30, and the solute permeation mechan-
ism is such that transport occurs in regions other than the water 
filled channels, agreement between theory and experiment should not 
exist and linear behavior of the data should not be found. Any devia-
tions from this plot could then be interpreted in terms of a mechan-
ism other than transport within the water ff11ed channels or pores. 
Yasuda et a1. (81-83) have studied the permeation of various 
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solutes including water through various hydrogel membranes. They 
found good agreement between theory and experiment for all solutions 
investigated. The water soluble solutes considered including urea and 
sodium chloride produced good agreements with the model when the 
diffusional data were plotted according to Equation 3-30. For water, 
good agreement was found with Equation 3-31 for hydrogels in which H 
varied over a wide range. 
Wisniewski and Kim (84) studied the transport of water and 
water soluble solutes in pHEMA based hydrogels. These authors showed 
that water transport data in pHEMA and copolymers of HEMA with MEEMA 
or MEMA were in good agreement with Equation 3-31. For water soluble 
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solutes in pHEMA it was found that plots of ln 0/00 versus r , where 
r is the cross-sectional radius of the solute, were linear. This 
result is also in agreement with the treatment of Yasuda et al. (81). 
Such behavior is implicit in Equation 3-30 in that 0 is related to the 
cross-sectional radius of the permeating solute. 
Several authors have considered the effects of crosslinking 
of pHEMA on the solute transport mechanism (84-85). Wisniewski 
et ale (84) showed that both the pore and the partition mechanism 
contribute to the transport of water depending upon the crosslinker 
concentration. A similar conclusion was reached by Zentner et al. 
(85) for the transport mechanism of progesterone in pHEMA films 
crosslinked with EGDMA. Upon a more detailed analysis of the data 
(86), they were able to define an approximate contribution of each 
mechanism (pore and partition), to the total transport in pHEMA. 
Based on the above it may be concluded that water and water 
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soluble solutes appear to transport pHEMA and copolymers of HEMA with 
MEEMA or MEMA primarily by the pore mechanism except at high concen-
trations of EGDMA whereas the partition mechanism dominates at high 
concentrations of this crosslinking. 
3.3.2 Effect of Initiator Concentration 
on Progesterone Permeation 
Through pHEMA 
It is well know that changes in polymerization conditions 
can affect the structure of the polymer formed (87). Since solute 
transport in polymer films is strongly dependent on structural proper-
ties, such studies should provide information about polymer structure 
with variations in the polymerization conditions. For example, Kapur 
and Rogers (88) investigated the transport properties of inert gases 
to determine the effects of aging on polyethylene film. In this 
laboratory, Zentner et al. (89) utilized studies on progesterone 
permeability in hydrogel films to determine the effects of the poly-
merization solvent on the properties of these films. Quite surpris-
ingly, they found that variations in the solvents (water, ethanol, 
and tert-butanol), and solvent concentration produced no significant 
change in the transport properties of the films. 
In the present study, the effects of the concentration of 
the initiator azobis(methylisobutyrate) on the transport properties 
of hydrogel films was investigated. The initiator concentration was 
varied from 7.84 to 31.36 mmoles initiator per liter of monomer. 
In all previous work from this laboratory (85, 88, 89, 90), the ini-
tiator concentration was held constant at 7.84 moles per liter of 
of monomer. Thus, the highest concentration used in the present 
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study was four times greater than the concentration routinely utilized 
in previous studies. Attempts to polymerize films at one-half this 
value failed. At a concentration of 3.92 mmole initiator per liter 
of monomer, polymerization was not complete. 
In Table 3.2, the permeability coefficients for progester-
one in pHEMA films are listed as a function of the initiator concen-
tration. It is apparent that the permeability coefficients decrease 
as the initiator concentration increases. This effect is rather small, 
i.e., a four-fold increase in the initiator contribution produces 
only a twenty percent decrease in P. This small effect is most likely 
due to an increase in the crosslink density as the initiator content 
increases. 
3.3.3 Effect of Crosslinker Concen-
tration on Estriol Permeation 
Through pHEMA 
Most previous work in this laboratory (85, 86, 88, 90) on 
solute transport in hydrogels has utilized progesterone as the model 
drug. This drug and the devices developed may have possible applica-
tions in the development of controlled release devices for contracep-
tive applications. It has been shown recently (91) that estriol may 
also be useful in such applications. The drug appears to be effective 
in utero at much lower concentrations than progesterone. With respect 
to the development of hydrogel devices for such applications, this 
could be of potential benefit since much smaller devices could be 
designed which would still be effective for at least one year. In 
view of this, a study of the permeation parameters for estriol in the 
hydrogel was initiated. 
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Table 3.2. Effect of Initiator Concentration on the Permeation Co-
efficients of Progesterone in pHEMA. 
Concentration of Initiator 
(m Moles/Liter of Monomer) 
7.84 m moles/liter monomer 
15.68 m moles/liter 





Permeation parameters for estriol in pHEMA crosslinked with 
EGDr~ are shown in Table 3.3. As expected, the permeability coef-
ficients decrease as the crosslinker content increases. In compari-
son with progesterone in the same membranes, these P values are smaller 
by a factor of about two (85). This is probably due at least, in part, 
to a decrease in the partition coefficients of estriol in these films 
relative to progesterone. Kd values for estriol are about a factor 
of two lower than progesterone in the same membranes. 
A direct comparison of the diffusion coefficients for pro-
gesterone and estriol in pHEMA membranes crosslinked with EGDMA is 
shown in Figure 3.2. In general, the diffusion coefficients for 
estriol are somewhat larger than for progesterone at the same cross-
linker content. Also, the variation of 0 with mole percent crosslinker 
follows a pattern somewhat different from that of progesterone. In 
particular, a limiting value of 0 for estriol at high concentrations 
of the crosslinker is not apparent. Based on this, it must be con-
cluded that the mechanisms of transport of this steroid may be some-
what different. This could be related to the role of membrane parti-
tioning in governing the mechanisms of solute transport. From the Kd 
values it was pointed out that estriol partitions somewhat less into 
these hydrogel membranes than does progesterone. This suggests that 
the pore mechanism of solute transport could be somewhat more important 
in estriol permeation through the range of crosslinker concentrations. 
The effective dose of estriol for contraceptive purposes is 
about 12 ~gm/day delivered ~ utero. This is about a factor of five 
less than that of progesterone (65 wgm/day). Unfortunately, this 
Table 3.3 Permeation, Partition, and Diffusion Coefficients for 
Estriol Through EGDMA Crosslinked pHEMA. 
Weigh Percent 
107 (m 2/Sec) 109 (m2/Sec) of EGDMA P x Kd D x 
0 3.80 56.1 6.78 
2.68 61.0 4.39 
3 1 .53 67,1 2.28 
5 0.834 73.3 1 . 14 
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Figure 3.2 A plot of diffusion coefficient versus mole percent of 
crosslinker. EGDMA crosslinker in pHEMA: ( 0) estri 01; (0) progesterone. 
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advantage of a reduced dosage in terms of hydrogel contraceptive de-
vices is reduced somewhat by the decrease in the permeability coeffi-
cient of estriol relative to progesterone. Nevertheless, it would 
appear that hydrogel devices prepared with estriol could be somewhat 
smaller than progesterone devices. In the ultimate application of 
the devices discussed in this thesis, such differences could be signi-
ficant. 
3.3.4 Solute Permeation Throu h 
Chitosan Membrane Effect 
of Functional Group on 
S01ute Permeation Through 
Hydrogel) 
Chitosan is a polymer of glucosamine Figure 3.3. It is 
found in plant cell walls (92) and is the most abundant component of 
the cell wall of filamentous and yeast-like forms of the mucor 
rouxii group grown under air and carbon dioxide atmospheres respec-
tively (93). Chitosan is usually prepared by a deacetylation reac-
tion of chitin which is a polymer of acetylated glucosamine (Figure 
3.3), This polymer can be obtained in large amounts from crab shells. 
Chitosan is a hydrogel whose equilibrium water content can be 
controlled by the method of preparation. Chitosan can be converted 
into a membrane by first making a water soluble salt of the polymer 
which is cast into films and then converted into free chitosan by 
treatment with a basic solution. The soft, yet tough, mechanical 
property of swollen chitosan makes this hydrogel a good candidate 
material for implant devices. 
In this study, solute permeation through chitosan membranes 
was investigated in order to test the potential of this polymer for 
-----) 
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use in drug delivery systems. Because of the free amino group present 
in chitosan, information concerning the interactions of solute func-
tional groups with this amino group during permeation can be ob-
tained. 
The equilibrium water content of chitosan (46 percent) is 
greater than that of pHEMA (41 percent). Based on this high water 
content and the theories of Yasuda et a1. (61,81-83), it is expected 
that solute transport in chitosan will occur primarily in the water 
filled pores or channels of the membrane. The data given in Table 
3-4 seem to be consistent with this hypothesis. 
Previous work from this laboratory (59) and others has demon-
strated that solute transport in hydrogels by the pore mechanism is 
strongly dependent upon solute size. This is evident from the data 
shown in Table 3.4 for both the pHEMA and the chitosan membranes. For 
example, by comparison of the P values for sucrose and water in the 
same membrane it is seen that sucrose is much less permeable than is 
water. However, the relative decrease in the permeability coefficient 
is much greater in pHEMA than in chitosan. This result suggests that 
the relative pore size in pHEMA is smaller than in chitosan. 
Na methotrexate and cocaine HCl are solutes which have larger 
cross-sectional areas than sucrose and, therefore, it is expected that 
both solutes would have permeability coefficients which are smaller 
than sucrose. From Table 3.4 it is seen that the permeability coef-
ficient for methotrexate in chitosan is larger than sucrose by about 
a factor of three. In contrast, the permeability coefficient for 
cocaine HC1 is lower than sucrose by about a factor of ten. These 
Table 3.4. Permeability Parameters for Solutes in Chitosan and pHEMA. 
Solute 7 2 p* x 10 (cm /sec) P x 107 ( sec) Kd KJ D* x (cm2/sec) o x 108(cm2/sec) 
Tritiated water 17.7 31.6 
Sucrose 0.114 0.514 
Na Methotrexate 1.09 1 .63 
Cocaine Hel 0.0547 
Progesterone 8.44 1.64 139 4.8 7.41 33.8 
Estriol 3.80 4.33 51 15. 1 7.39 28.8 
*Data for pHEMA membrane (59). 
U1 
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results can best be interpreted in terms of specific charge effects 
between the solutes and the membrane. Due to the amino group in 
chitosan, the membrane carries a net positive charge. This positive 
charge should retard the passage of cocaine due to like charge repul-
sion. For methotrexate, which has a negative charge, ionic charge 
attraction between drug and the membrane could account for the en-
hanced permeability of this solute relative to sucrose. 
Based on the above, it can be concluded that chitosan appears 
to behave as a pore type membrane in terms of the solute transport 
mechanism. However, the permeability coefficients can be strongly 
influenced by specific interactions, especially charge-charge interac-
tions, between the membrane and solute. 
Such specific interactions also appear to be important with 
the two hydrophobic solutes investigated, namely, progesterone and 
estriol. For example, again by comparison with the sucrose data 
and the solute size argument, it would be expected that the perme-
ability coefficients for these solutes in the same membrane would be 
similar and that the P values in chitosan would be about four times 
greater in chitosan than in pHEMA. Based on Table 3.4, it is appar-
ent that this predicted behavior is not found in the permeability 
coefficients. Such differences could arise from specific interac-
tions between the solute and the membrane which are best explained 
via the membrane partition coefficients. These values are listed 
in Table 3.4 for progesterone and estriol in both membranes. 
By comparison of the Kd values, it is apparent that chitosan 
and pHEMA differ substantially with respect to their solute 
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partitioning behavior. Progesterone, which has a very high partition 
coefficient in pHEMA, produces a very low Kd value in chitosan. In 
contrast, the estriol Kd values differ by much less between the two 
membranes and do not show the same order. Such differences emphasize 
the difficulty in predicting the effects of functional groups'on the 
solubilities of drugs in various media. 
Given Kd values, solute diffusion coefficients can be cal-
cu1ated from the relationship P = DKd. The diffusion coefficients 
for estriol and progesterone are given in Table 3.4. The diffusion 
coefficients follow the behavior predicted previously for the P values 
for thse solutes. In both films, the diffusion coefficients are very 
nearly the same. This is expected based on the similar cross-sec-
tiona1 radii. Also, the 0 values in chitosan are about four times 
greater compared to pHEMA. This is consistent with the argument 
presented earlier, that is, pHEMA is a membrane with a much smaller 
average pore size than chitosan. 
3.4 Solute Permeation Through Copolymer 
of HEMA and MMA 
Though the minimum interfacial free energy hypothesis develop-
ed by Andrade et al. (11-13) may predict biocompatability of polymers, 
other studies (19, 21, 22, 94) have shown that an adequate amount of 
water is necessary for biocompatabi1ity rather than just high water 
content alone. Quite recently, Ratner et al. (14) found that a co-
polymer of HEMA and EMA (ethyl methacrylate) whose water content is 
around fifteen percent has better blood compatabi1ity as measured by 
platelet consumption than a polymer with higher water content. 
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According to this IIhypothesis of a balance of polar and a polar 
sites" at the polymer surface (14), it may be possible that some of 
the copolymers composed of HEMA and MMA will show better biocompa-
tability than pHEMA membrane. 
It is also probable that some of these copolymers of HEMA 
and MMA have stronger mechanical properties than pHEMA due to de-
creased water content. In case of reservoir type device of contra-
ceptive drug delivery system the required thickness of the device 
is less than 1 mm. Therefore enhanced mechanical property is quite 
important. Because of the possibility of better biocompatabi1ity and 
strong mechanical property, steroid transport through these copoly-
mer of HEMA and MMA is studied to test these polymers for contracep-
tive drug delivery systems. Water transport in these copolymers was 
studied first to know better understanding of the mechanism of trans-
port. 
Table 3.5 shows permeation parameters of tritiated water 
through copolymer of HEMA and MEMA. Figure 3.4 are plots of volume 
and weight fraction of water versus weight percent of MMA. Both 
weight and volume fraction decrease somewhat linearly as the frac-
tion of MMA increases. 
A plot of the diffusion coefficient of water versus weight 
percent of MMA is shown in Figure 3.5. The diffusion coeffificents 
decrease as the MMA content increases in a nonlinear relationship. 
However, the leveling of diffusion coefficient at high concentration 
of MMA is not observed. If water permeates by the partition mechan-
ism, the diffusion coefficients are expected to reach certain value 
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Table 3.5. Permeation, Partition, and Diffusion Coefficient for 
Tritiated Water Through HEMA-MMA Copolymer and Fraction 
of Water in the Copolymer. 
Weight Percent 
107{cm2jsec) 6 2 of MMA P x Kd Wf D x 10 (cm jsec) 
0 17.9 0.523 0.410 3.42 
2.6 0.516 0.385 
5. 1 13.42 0.474 0.363 2.83 
9.2 9.82 0.457 0.354 2.15 
18.3 4.83 0.350 0.274 1 .38 
32.7 0.285 0.230 
37.3 1 . 17 0.229 o. 184 0.51 
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Figure 3.4. A plot of water content versus weight percent MMA 
in co po 1 ymers of HEHA and t~MA. (0) = volume; 


























Wt. % M M A 
Figure 3.5. A plot of diffusion coefficients of water versus percent 
MMA in copolymers of HEMA and MMA. 
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at high concentration of MMA. The above findings may indicate that 
the pore mechanism is dominant throughout the range of MMA concentra-
tion used. 
Table 3.6 shows the values of (lnDIDo)-l and X- l for various 
( - 1 - 1 MMA concentrations. Figure 3.6 is a plot of lnDIDo) versus X . 
A good linear relationship (a correlation coefficient of 0.99) indi-
cates that Yasuda's free volume theory applies well to this system. 
Permeation parameters of progesterone and estriol through 
copolymers of HEMA and MMA are shown in Table 3.7 and Table 3.8 res-
pectively. In Figure 3.7 the diffusion coefficients of estriol and 
progesterone are plotted against percent MMA. The diffusion coef-
ficients of estriol decrease quite rapidly as the MMA content reaches 
approximately twenty percent and then decreases somewhat slowly 
after that. This may be interpreted to mean that for this solute, 
a pore mechanism is dominant at MMA contents of twenty percent or 
less and that a partition mechanism is dominant after that. 
In Figure 3.8, plots of the partition coefficients of two 
steroids versus percent of MMA are shown. It is interesting to note 
that the partition coefficients can have maximum values. In the 
general case there is a correspondingly continuous increases or de-
crease in the partition coefficient of the solute for a copolymer 
series where the fraction of one of the components increases. 
The partition coefficient is related to the interaction between 
solute and membrane. The intensity of the interaction should in-
crease or decrease continuously as the fraction of one component of 
copolymer increases and if the membrane can be thought of as being 
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-1 1 Table 3.6. Values of (In 0100) and X- for Tritiated Water in 
HEMA-MMA Copolymers. 
Weight Percent )-1 -1 Of MMA In(OIOo X = KOI (1- KO) 
0 - 0.527 1 .098 
5. 1 - 0.479 0.900 
9.2 - 0.423 0.842 
18.3 - 0.356 0.539 
37.3 - 0.263 0.296 
47.3 - 0.240 0.243 
















Figure 3.6. Plot of (lnO/Oo)-l versus X- l for tritiated water 
in HEMA-MMA copolymers. 
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Table 3.7. Permeation, Partition, and Diffusion Coefficients for 
Estriol Through HEMA-MMA Copolymers 
Weight Percent 
108(cm2/sec) 1010(cm2/sec) of MMA P x D x 
0 38.0 51. 26 74.1 
5. 1 26.7 70.03 38.1 
9.2 14.8 74.17 20.0 
18.3 4.84 84.38 5.74 
32.7 0.575 55.46 1 .04 
37.3 0.319 25.91 1 .23 
47.3 0.182 24.21 0.751 
D = 0 6.8 x 10-
6 cm2/sec (78) 
Table 3.8. Permeation, Partition, and Diffusion Coefficients for 
Progesterone Through HEMA-MMA Copolymer. 
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Weight Percent 
1 07 (cn,2 / sec ) 109(cm2/sec) of MMA P x Kd D x 
0 10.3 139.34 7.39 
2.6 7.79 180.25 4.32 
5. 1 5.82 218.51 2.66 
9.2 3.51 237.69 1 .48 















Wt % M M A 
Figure 3.7. Diffusion coefficients of progesterone and estriol as 
a function of weight percent MMA in copolymers of HEMA 





W t % M M A 
Figure 3.8. Partition coefficients of progesterone and estriol as a 
function of weight percent MMA in copolymers of HEMA 
and Mt~A. (0) = progesterone; (0) = estriol. 
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homogeneous. The appearance of a maximum partition coefficient may 
be explained by the following assumptions. The membrane is composed 
of hydrophilic domains scattered through a hydrophobic matrix and 
hydiogen bonding is possible between steroid and hydrophilic domain. 
The size of domain and distance from one domain to another domain is 
determined by the ratio of hydrophilic monomer to hydrophobic monomer. 
A maximum interaction occurs when the hydrophobic portion of the 
steroid molecule faces the matrix and the functional groups of 
the steroid faces the hydrophilic domain. In the case of a copolymer 
of HEMA and MMA, optimal matching of hydrophobic and hydrophilic por-
tion takes place when the fraction of MMA is around twenty percent. 
In the course of this work it became of interest to investi-
gate the applicability of the theories of Yasuda et al. (61, 77-83) 
to the transport of water and hydrophobic solutes in the pHEMA based 
hydrogels. In section 3.3.1 the basic equations of the Yasuda theory 
were outlined. For transport of water soluble solutes in which trans-
port occurs only within the free volume of the water, Equation 3-30 
is valid. For transport within the total free volume of the polymer, 
Equation 3-31 should be valid provided that the activation energy for 
transport is the same irrespective of the region of solute transport. 
When solute transport occurs through the total free volume 
-1 -1 
of the polymer, a plot of (In DIDo) versus X should be linear 
with an intercept of -a/S(l-a) and a slope of -l/S(l-a) where a = 
Vf,o/Vf,l and 6 = V*/V f ,l' In general, such plots are linear. This 
has been shown by Wisniewski et al. (84) for water transport in co-
polymers of HEMA with MEMA or MEEMA. Zentner et a1. (85) found the 
66 
same result with progesterone in these copolymers. As mentioned pre-
viously the plot in Figure 3.6 also is linear for the permeation 
of water in copolymers of HEMA and MMA. These results suggest that, 
in general, the Yasuda theory is valid for the case where the total 
free volume (polymer plus water) is considered. 
As an adidtional test of the theory,it was of interest to 
consider the relative consistency of the results for different solutes 
in the same polymers. For example, for water and progesterone trans-
port in the HEMA copolymers, the value of a should be independent of 
solute size whereas should be size dependent. The latter conclusion 
is based upon the fact that V* should be size dependent. In order 
to investigate these points, all available data from these labora-
tories (59, 77) were plotted according to Equation 3-31. The slopes 
and the intercepts of these plots were determined by linear regres-
sion analysis. For all systems considered except HEMA-TEGDMA, the 
correlation coefficients were greater than 0.90 and, in most cases, 
greater than 0.95. From the slopes and the intercepts of these 
plots, values of a and 8 were determined for each system considered. 
Based on the discussion above, all values of a in the same 
polymer system should be a constant, or nearly so. Also, the dif-
ferences in a should be dependent only upon the free volume of the 
anhydrous polymer. It is expected that these values should be some 
function of monomer geometry. From the data in Table 3.9 no apparent 
trend in the values of a is discernable. For example, in HEMA-MMA 
copolymers, water and progesterone yield the same value of a. How-
ever, a for estriol is much higher. The consistency of the 
Table 3.9. Comparison of the Parameters a and B for Water, Progesterone, and Estriol in 
Various HE~lA Polymers. 
Solute Water Solute = Progesterone Solute = Estriol 
Polymers a S a S a. S 
HEMA-MMA Copolymers 0.5268 6.510 0.5311 23.87 0.9543 306.7 
HEMA-MEMA or 
MEEMA Copolymers 0.6885* 11.14* 3.354* - 13.87* 
HEMA + EGDMA 1.767* -7.663* 0.8530* 95.69* 0.6659 36.15 
MEMA + TEGMA 2.387* -5.160* 3.171* - 14. 14* 




calculated value of a would not be improved significantly by exclud-
ing those copolymers which appear to have a different mechanism 
of solute transport based on Figure 3.9. For copolymers of HEMA 
with MEMA or MEEMA, the value of a obtained from water transport is 
somewhat larger than that of the HEMA-MMA copolymers. However, the 
value for a obtained from the progesterone study in this copolymer 
is very high and seems to be inconsistent with any plausible model 
for the copolymer free volume. The same can be said for most values 
of a obtained in the crosslinked polymers. 
The values of 6 shown in Table 3.9 show even greater scatter 
than the a values just discussed. In many systems negative values 
of B result. This is not physically possible since B is the ratio of 
two volume terms. 
Based on this discussion, it is apparent that even though all 
systems studied provide good linear correlations when plotted accord-
ing to Equation 3-31, the expected behavior of these systems with 
respect to a and B is very far from the expected behavior. Some of 
this inconsistency would be due to experimental error, especially in 
the H value. It is unlikely, however, that this is the total source 
of the error. It is more likely that some of the inconsistency lies 
in the fact that the theory may not be applicable to hydrophobic 
solutes and/or to those systems in which solute transport occurs in 

















1 -1 Plot of (lnO/Oo)- versus X for estriol in HEMA-
tvtMA copo 1 yme rs . 
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Chapter 4 
PROGESTERONE RELEASE FROM MONOLITHIC DEVICES 
4.1. Introduction 
Monolithic devices have been extensively studied for the pur-
pose of controlled drug delivery. A monolithic device consists of 
drug molecules either physically dispersed or chemically dissolved 
(in a thermodynamic sense) within a polymeric matrix. Monolithic de-
vices are advantageous in that fabrication methods are easily modi-
fied to produce a wide variety of device designs; however, the in-
herent first-order release kinetics cannot provide stable blood and 
tissue drug levels as a function of time. As a result, such devices 
are not ideally suited for pharmaceutical application, but rather, 
are powerful tools for evaluating drug permeation factors and release 
kinetics from polymer matrices. In this chapter, two aspects of the 
release of solutes from monolithic devices containing dispersed drugs 
are evaluated. In the first section, a new equation will be developed 
which describes the release of drug from such devices. In the next 
section, it will be shown that this equation adequately describes the 
release pattern for all cylindrical geometries irrespective of the 
length of the cylinder. In the last section of this chapter, the re-
lease of progesterone from monolithic hydrogel devices will be evalu-
ated. Particular attention is devoted to the role of water uptake 
by the devices on the observed release rates. 
4.2.1 Derivation of Equation for Drug 
Release from Cylindrical 
Geometry 
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It is well known that drug release from monolithic devices is 
dependent upon the matrix geometry. Although the configurations of 
the systems may vary greatly, the systems may be geometrically cata-
gorized into three types. These are: (i) slabs, (ii) cylinders or 
rods, and (iii) spheres. Of these configurational types, cylinders 
are the most frequently used for practical purposes. 
Models for the release of drug from slabs and spheres have 
been well developed by Higuchi (95, 96). Diffusion models from 
cylinders are more complex and two cases may exist. For long cylin-
ders, in which the relative contribution of drug release from the 
ends of the cylinder (end effect) is negligible compared to the amount 
of drug release that takes place along the longitudinal axis of the 
cylinder, Roseman and Higuchi (97) developed a kinetic model to des-
cribe the release rate from such devices. For finite cylinders in 
which end effects cannot be neglected, Cobby et a1. (98-100) and Fu et 
al. (101) have developed appropriate kinetic models and derived the 
corresponding release rate equations. Cobby's treatment can be fitted 
to experimental data and readily converts to the slab case when the 
longitudinal axis becomes exceedingly small. However, his equation 
cannot be converted to a long cylinder where end effects are neg1igi-
ble. The incompleteness of Cobby's equation comes from the incorrect 
assumption that the drug boundary retreat distance ;s proportional to 
square root time regardless of matrix geometry. In general, this 
proportionality does not apply (96, 97), except in the case of slab 
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geometry. Fu's treatment fits well with experimental data and con-
verts to slab and long cylinder cases when appropriate approximations 
are made for certain terms in the finite series comprising the final 
equations describing drug release. A further disadvantage of both 
of these treatments, relative to that of Roseman and Higuchi, is 
that computer analysis of the data is required. 
It is the purpose of the following development to derive an 
equation for the release rate from cylindrical monolithic devices 
based on the assumption that drug diffusion at the longitudinal sur-
faces follows Roseman1s Equation (97) and that drug release at the 
end surfaces occurs as described by Higuchi (95). The validity of 
the new equation will be tested using progesterone disperced in a 
silicone matrix as a model system, where the radius to height ratio 
will be varied over a wide range. 
Under the condition where the total amount of drug in the 
matrix per unit volume, Co, is much greater than the drug's matrix 
solubility, Cs, a quasi-steady state exists and diffusion is con-
trolled by the matrix. The following equations were derived for the 
planar (95), and the long cylinder cases (97), adhering to the above 




-co t (4-1 ) 
and 
Mt :: A (2 Co DCs t)1/2 ( 4-2) 
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Where X is the bou~dary retreat distance, D is the diffusion coeffi-
cient in the matrix, A is the surface area, and Mt is the amount of 
drug released at the time t. 











where r is the radius at the boundary retreat distance, ro is radius 
of the cylinder, and F is the fraction of drug released. 
As time progresses, the release boundary, the area where 
dissolution of solid drug occurs, retreats from the polymer surface 
as shown in Figure 4.1. The height (h) of the cylinder will 
change following Higuchi's equation. 
~ h = ho - 2/ ~-C- t 
o 
(4-5) 
where h is the initial height of the cylinder. The radius of the 
o 
cylinder will change according to Equation 4-3. 
(4-3) 
The total amount of drug in the matrix (M 00) can be expressed as: 




Because of the assumption that Co» Cs ' the amount, Mt, of drug re-
leased at time t will correspond to the difference between M 00 and 
the amount of drug in the shaded volume in Figure 4.1. The drug 
remaining at the time t is equal to rrr2 h C. Therefore, 
o 
Mt = 2 rrr h C o 0 0 (4-7 ) 
The fraction of drug release can be obtained from Equations 4-6 
and 4-7. 
F = Mt 
00 
2 C 2 rrr h - rrr h C 
= 
0 0 0 0 
2 




= - 2 
ro ho 
Equation 4-4 can be introduced into Equation 4 to give the 
following equation: 








(1 - F)/(l - /at ) (4-10) 
where 
a = 
Equation 4-10 can be combined with Equation 4-3 to give the fol-
lowing equations: 




- b Ikt 
- F 
+ 1 - - F 
- lat 1 - /at 
ln _-_F __ + 1 -
- b /kt 
- F k 
----= -t 
- b /kt 2 
( 4- 11 ) 
( 4- 1 2 ) 
where b is the ratio of radius to height of the device (r /h ) and 
o 0 
k = (4-12a) 
Equation 4-12 is the final equation which describes drug release 
from a polymer matrix device of cylindrical geometry. This equation 
is simlar, though more elaborate than Equation 4-4, which was de-
rived for a long cylinder where end effects are neglected. In prac-
tical application, k values are determined so that the equation can 
be made to 'fit' the experimental data. Diffusion coefficients can 
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be obtained from k values using the following equation: 
D = 





Permeability coefficient, P, can be obtained from the diffusion co-
efficient, D, by the following relationship: 
P = DKd (4-14) 
where Kd is the partition coefficient for the drug between polymer 
and water phases. 
To be valid, an equation which describes a release mechanism 
should predict release kinetics in special cases such as long cylin-
ders and slabs. In the case of long cylinders, the value of b, 
which is the ratio of radius to height of the cylinder, is very 
small. When b approaches zero, 1 - b Ikt becomes 1, and Equation 
4-12 reduces to 
(1 - F) ln (1 - F) + F 1 = "2 kt (4-15) 
which is the equation for long cylinders where end effect are ne-
glected. 
The slab can be represented by another extreme case for 
cylinders where the height of cylinder is insiginificant compared 
to the radius of the cylinder (i .e., ro» ho)' If ro is very large, 
the right side of Equations 4-11 or 4-12 will approach zero. 
1. kt 2 
40C 





Under this condition, both equations convert to Equation 4-17. 
- F ln - F + 1 - - F 
- rat - rat - rat 
The solution of Equation 4-17 is as follows: 
where 





which is the equation for the slab case. 
4.2.2 Progesterone Release from Cylindrical 
Monolithic Devices: Comparison of 
Experimental Release Rates with 
Various Mathematical Models 
= 0 (4-17) 
(4- 18) 
In Section 4.2.1, various mathematical models for drug re-
lease from cylindrical monolithic devices containing drug dispersed 
in the matrix were presented. It was argued that previous models 
adequately describe the release rate from long cylinders. However, 
for devices in which the ratio of the radius to the height is rela-
tively large, it was suggested that extensions of previous equations 
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were required to provide an adequate description of the release rate 
from these devices. A new equation was developed to meet this need. 
In this section, the release of progesterone from cylindri-
cal monolithi'c devices will be examined in terms of the previous 
model and the equation developed in this thesis. 
Cylindrical devices containing two percent progesterone by 
weight were prepared. The radii and heights of the devices varied 
so that the ratio b varied from 0.05 to 0.28. The release of pro-
gesterone from these devices was followed over time until the frac-
tion released, F, was at least 0.90. These release curves are shown 
in Figures 4.2 thru 4.4. 
Permeability coefficients for progesterone in each device 
were developed via Equation 4-12. In essence, this was done by 
picking values of k (Equation 4-12), and comparing the predicted 
versus experimental values. The value of k was adjusted to give the 
best fit to the experimental release curve. For each time, the value 
of F was calculated from k using the Newtonian iterative technique. 
Because diffusion coefficients as well as permeabi1ities of 
devices are unique properties of a given matrix polymer composition, 
these values should be independent of device geometry. Values of 
permeability and diffusion coefficients for each sytem which have a 
different b value are shown in Table 4.1. Each experiment gives 
the same value of permeability and diffusion coefficients. Further-
more, the rlease rate calculated according to Equation 4-12 are 
































































































































































































lData obtained by Equation 4-12. 











full range of release. This is shown by the dashed line in Figpures 
4.2 to 4.4. Therefore, it is concluded that Equation 4-12 ac-
curate1y reflects the release behavior of solutes from cylindrical 
monolithic devices for all values of b. 
For comparison, the permeability and diffusion coefficients 
for progesterone in these devices were calculated by means of Equa-
tion 4-4. 1 This was done by plotting [(1 - F)ln (1 - F) + FJ~ versus 
t~. P is obtained from the slope of this plot. The values obtained 
are shown in Table 4.1. It is apparent that as b increases, the 
calculated P (and D) values increase with successively increasing 
deviations from the value obtained via Equation 4-12. 
In the practical application of these equations, a compro-
mise between time spent in data analysis and accuracy may be required. 
Fron the data given in Table 4.1, it may be concluded that if b 
is less than about 0.10, calculated values of P will be approximately 
the same with both Equations 4-12 and 4-4. However, if b is more 
than 0.1, Equation 4-12 will rrovide a more accurate estimate of 
P and the time spent in data analysis may be justified. 
4.2.3 Progesterone Release from Mono-
lithic Hydrogel Devices 
Drug release kinetics from monolithic devices containing 
drugs dispersed within the polymer matrix has been extensively in-
vestigated (102). Most of this work has dealt with the release of 
solutes from polymers, such as polydimethylsiloxane, which do not 
swell in the presence of solvent. In contrast, very little work has 
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been done on the release of drugs from polymers, such as the hydro-
gels, which swell in the presence of water. Recently, Good (103) 
presented an in-depth study of the release of a water soluble drug 
from hydrogels with slab geometry. In this study, the total drug 
present was soluble in the polymer matrix at equilibrium swelling. 
Graham (104) has also studied the release of drug from hydroge1s of 
slab geometry in which the drug was present below its saturation 
solubility at equilibrium swelling. 
In this section, data on the release of progesterone from 
cylindrical hydrogel devices which are initially dry are presented. 
The release rates are evaluated with respect to the effects of water 
uptake, initial drug load, and the equilibrium water content of the 
devices. 
Based upon the study presented in Section 4.2.2, it was 
concluded that drug release from cylindrical devices, which have a 
ratio of the radius to length of less than 0.10, can be adequately 
described by the equation of Roseman and Higuchi (97). The devices 
prepared for the present study have dimensions of 4 cm in length 
by 0.25 cm in radius (b = 0.063). Therefore, the release rates 
should be consistent with the treatment of Roseman and Higuchi 
(Equation 4-4), 
When F is plotted versus time, according to Equation 4-4. 
a nonlinear plot is obtained such that negative deviations occur 
with time. However, at early times, F is linear with time. The 
rationale as to why this occurs can be developed from a comparison 
of the initial release rates from devices of any geometry with the 
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initial release rates from slabs. Using the hypothesis, Roseman 
(105) has shown that the initial release rate from cylinders can be 
described by 








The validity of Equation 4-19 was tested by Roseman (105). 
By comparing plots of F versus t 1/ 2 for both Equations 4-4 and 4-19, 
where K was arbitrarily set at 1.0 day-l, Roseman concluded that 
Equation 4-19 provides a good approximation of the ini al release 
rate from cylinders. Significant deviations (greater than 10%) do 
not occur until F is greater than about 0.50. 
For several of the systems investigated in the present study, 
(Figures 4.5 to 4.10, plots of F versus follow the pattern sug-
gested by Equations 4-4 and 4-19. During the early stages of drug 
release, these plots are linear. When t becomes large, the plots 
show the expected negative deviations from linearity. Based on this, 
it may be concluded that, in general, drug release rate from hydro-
gels follows the trend predicted based on theories developed for 
polymers which do not swell in the eluting solvent. 
Such behavior was not universally observed. Figures 4.11 
and 4.12 are piots of F versus t 1/ 2 for the release of progesterone 
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Figure 4.6. A plot of F versus (hours)1/2. Open circles are experi-
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Figure 4.7. A plot of F versus (hours)1/2. Open circles are experi-
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Figure 4.9. A plot of F versus (hours)1/2. Open circles are experi-
mental points; solid line used to determine slope and 
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MEEMA and HEMA (monomer mole ratio 2:1) (Figure 4.12). The initial 
drug loading of these devices were 16.0 and 9.1 weight percent, 
respectively. Both plots appear to be best represented by two 
straight lines with a discernable breakpoint during the early stages 
of release. The existence of these breakpoints was confirmed from 
plots of ~Mt/~t versus t. This function is constant in each case 
until about eight hours in root time. At times greater than this, 
Mt/~t is again constant but its value is somewhat greater. 
Also given in Figures 4.11 and 4.12, are plots of the water 
uptake of these devices (defined as the increased weight of hydrated 
polymer/initial weight of the nonhydrated device) versus the square 
root of time. The breakpoints in these curves correspond with those 
in the drug release curves. Based on this, it is suggested that the 
influx of water into the device may influence the release rate of 
drug from the device. From the observed smaller slope in the drug 
release curve before the breakpoint, it can be concluded that drug 
release is slower during the early stages of release. The slower 
rate of drug release may arise due to the interaction between the 
influxing water and eff1uxing drug. If progesterone transport occurs 
mainly through the water filled pores of the hydrogel, the friction-
al force between the solute and the water present in pores will con-
tribute an energy barrier for solute diffusion through the hydrogel 
membrane (106). Work (84, 86) from this laboratory has shown that both 
water transport and the permeation of steroids occurs predominately 
through the water filled pores of the hydrogels. This indicates 
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that before the breakpoint is reached, a counter flow of the solute 
and water occurs in these pores. This counter flow is thought to 
provide an additional resistance to solute diffusion. The duration 
of this effect is dependent on the water saturation time. 
In the following, an empirical parameter, Q, will be de-
veloped which will serve as a semiquantitative measure of the magni-
tudes of these crossflows. The magnitude of Q will be compared with 
the experimental results obtained from the drug release curves. 
The rate of drug release is dependent upon the permeability 
of drug in the device. These values were determined from the slope 
of drug release curves. According to Equation 4-4, a function f 
(F) may be defined as follows: 
f (F) = [(1 - F) ln (1 - F) + FJ 1/ 2 = Kl/2 tl/2 (4-20) 
where 
K = (4-20a) 
When f (F) is plotted versus tl/2, a linear plot should be obtained 
which has a slope of Kl/2. For cases in which a breakpoint is ob-
served, Kl/2 was obtained from the slope of the plot above the break-
point. The permeability coefficient, P, can be obtained from K and 
Equation 4-20a as follows: 
K = = 
4PCw 
C r 2 
o 0 
(4 -21 ) 
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where P = DKd, Kd = Cs/~' and ~ is the satuaration solubility of 
progesterone in water. 
It is hypothesized that the effect of water influx on the 
drug release rate is proportional to both the rate of water influx 
and the rate of drug efflux. According to this hypothesis, the pro-
duct of the two rates should give a value which provides a measure 
of the effect of water uptake on drug release. 
The rate of drug release is dependent on many factors as 
shown in Equation 4-19. In order to obtain the main factors which 
affect the release rate, the equation is further treated. From 
2 Equation 4-19, it can be shown by substitution of TIro ho Co for 
M 00 that Mt is given by 
(4 -22) 
or by substituting P for DKd 
Mt = (8 n2 h2 r 2 C C P t)1/2 
o 0 0 w 
(4 -23) 
where h is the height of the device. For this experiment, nearly 
o 
identical devices were used so ro and ho can be assumed constant for 
all devices studied. It is apparent from Equation 4-23 that Mt is 
proportional to the square root of both the initial drug load and 
the permeability of the solute. 
From Equation 4-25, it may be concluded that P and Co are 
the parameters which should control the relative release rate of 
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progesterone from the various devices investigated. The rate of 
water influx ;s dependent upon the permeability coefficient of water 
in each device. This value cannot be determined directly, however, 
the rate should be proportional to the slope, S, of the water influx 
curve. Accordingly, the empirical parameter, Q, can be defined as: 
Q = S~ (4- 24) 
This semi-empirical parameter should give a relative measure of the 
interaction arising from the counter-flows of the solute and water 
at the early stage of drug release. Values of Q, the water satura-
tion time, and the presence of the breaking point are shown in Table 
4.2. 
A breakpoint in the drug release curve is observed when the 
-6 
va 1 ue of Q is grea ter than abo ut 5 x 10 cm/ sec. Thus, as the 
magnitude of the solute and water crossflow increases (as measured 
by the parameter Q), breakpoints occur in the drug release curve. 
The absence of a breakpoint in the drug release curve for the matrix 
prepared from MEEMA can be explained by this method. This device 
has the highest equilibrium water content and is expected to be 
affected the most by water uptake. However, the value of S, slope 
of water influx, is rather small compared with that for HEMA de-
vices. Therefore, the magnitude of the counterflow of solute and 
solvent is too small to show the presence of a breakpoint. 
In order to calculate the permeability coefficients listed 
in Table 4.2, Equation 4-21 was used. In this case, it is 
Table 4.2. Release Characteristics for Progesterone from Monolithic Hydrogel Devices. 
Initidl PerHledl>i~ity Slope of 
.. "_"_"_. __ "._ ... __ .l·lonomer_s _____ ~l¥~w~~)~____ __ ___ ~m~/~~c ______ . __ p~~~ _lhi~~72 )_.~~t. T~~~er(hr-1/2} ,_ ... , Q x 10'" {rm/s~_ 
MEEMAa 7.8 3.64 0.44 14 3.9 
67% MEEMA 
33% HEMAb 9. 1 2.01 0.78 8.2 5.56 
HEMA 16.7 1. 55 0.60 8 5.09 
HEMA 13,0 1.22 0.63 9.5 4.18 
tlEMA 9.1 1.05 0.65 7.5 3.35 
IfE~IA 4.8 0.88 0.67 7.5 2.30 
80% BEMA 
20% MEMAc 9. 1 0.61 0.34 8.0 1.34 
67% HEMA 


















'necessary to know the aqueous solubility of the solute in water. 
In case of hydrophilic solutes, aqueous solubilites are usually easy 
to obtain. However, it is relatively difficult to obtain accurate 
aqueous solubility data for hydrophobic solutes like progesterone 
(107). In this study, a value of 38 ~gm/ml was used based on the 
average value obtained from three methods described in Section 2.2.2.1 
This value is about three times higher than that of 11.4 ~gm/ml given 
by Roseman (105). Considering the fact that Roseman's data was ob-
tained at 37°C while the value presented here was obtained at 23°C, 
present data is much higher. 
Such differences in the aqueous solubility will strongly af-
fect the measured values of the permeability coefficient obtained 
by using Equation 4-21. Because of this, a second method was de-
veloped to determine progesterone permeability in the monolithic 
devices. When permeability coefficients are calculated from studies 
of the rate of transfer of a solute across a thin film using a dif-
fusion cell, the P values can be obtained directly from plots of 
concentration variation versus time using Equation 3-14 derived in 
Section 3.2.1. 
Table 4.3 shows the values of P and 0 obtained from pro-
gesterone transport study through hydrogel films together with those 
from progesterone release study from cylindrical monolithic devices. 
The films used in this study were prepared with the initial drug 
loadings listed in Table 4.3, and then depleted of drug before the 
permeation experiments were performed. This table shows that there 
is good agreement between the two sets of P values obtained by 
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102 
separate methods. This agreement between P values provides further 
evidence that the aqueous solubility of progesterone is close to 
38 ~gm/ml. In fact, these two methods of obtaining permeability 
may be used to determine the solubility of slightly soluble solutes 
in aqueous solution. 
Further support for this hypothesis can be generated from the 
paper of Roseman (105). In this paper (105), Roseman obtained two dif-
ferent values of diffusion coefficients of progesterone in silastic 
rubber. One value, obtained from lag time method, was 4.50 x 10-7 
cm
2/sec. A second value, obtained from matrix release studies, was 
16.5 x 10-7 cm 2/sec. These values together with the reported aqueous 
solubility value (11.4 ~gm/ml) can be used to predict the aqueous 
solubility of progesterone. When the data were treated with the 
proper manipulation of Equation 4-21, 41.8 ~gm/ml was obtained. 
This value ;s in good agreement with that obtained in the present 
study. 
In order to study the effect of initial drug load on the 
transport properties of the matrix, permeability parameters of the 
monolithic devices were compared with that of the polymer system 
which has the same polymer composition though there is no initial 
drug load. Table 4.4 shows literature values of P, Wf , and Kd of 
the polymer system without initial drug load (85), together with 
the permeability coefficient obtained in this study. Table 4.4 
shows that the permeability of the initially drug-filled polymer is 
greater than that of the same polymer without initial drugs. This 
Table 4.4. Comparison of Permeation Parameters Between Drug Depleted Film and Film Prepared 
Without Drug. 
Initial pa x 106 pb x 106 Drug Load W b K b 
Monomers {% w&_ ec) f d 
MEEMAd 7.8 3.64 2.5 0.723 
67% MEEMA 
33% MEMAc 9.1 2.01 1.53 0.504 129 
HEMA 16.7 1 .55 0.84 0.423 129 
13.0 1 . 0.84 0.423 129 
HEMA 9.1 1 .05 0.84 0.423 129 
HEMA 4.8 0.88 0.84 0.423 129 
80% HEMA 
20% ~1EMA f 9. 1 0.61 0.29 0.340 156 
67% 
33% HEMA 9. 1 0.44 0.30 0.308 192 
aFrorn drug depleted film 
bFrom film prepared without drug (85) 
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increase ;s proportional to the initial drug loads as shown by the 
data with pHEMA. This may be interpreted that the presence of drug 
during polymerization affects the average pore size of the resulting 
polymer. 
The effect of initial drug loading on the equilibrium water 
content was also studied. The equilibrium water contents of the mono-
lithic devices after drug depletion were greater than those of same 
polymer systems without initial drug load. However, the equilibrium 
water contents of the drug depleted devices agree with those obtained 
in pHEMA films prepared without drug (85). 
Table 4.3 shows that the progesterone permeability in mono-
lithic devices increases as the equilibrium water content of drug 
depleted polymer increases. Same phenomena is observed in the drug 
pernleation through polymer membrane without any initial drug load as 
shown in Table 4.4. The partition coefficients shown in Table 4.3 
obtained on the drug depleted films are, in general, quite close to 
those obtained on the same polymer systems without initial drug 
load. This indicates that the introduction of drug into matrix 
device does not affect the equilibrium solubility of progesterone 
in the polymer matrix. The independence of drug solubility and 
dependence of drug permeability on the drug incorporation may be 
interpreted that the pore mechanism is predominant in progesterone 
permeation through hydrogel membrane. If progesterone permeates 
mainly by the partition mechanism, it is expected that increased value 
of permeation coefficient is accompanied by the change of drug 
solubility in polymer (78). 
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From the study of progesterone release from monolithic 
devices it can be concluded that release rate of drug is affected 
by: (i) water content of swollen devices, (ii) initial drug load, 
(iii) rate of water uptake, and (iv) that progesterone permeates 
through hydrogel membranes mainly via pore mechanism. 
Chapter 5 
PROGESTERONE RELEASE FROM RESERVOIR AND COMBINED DEVICES 
5.1. Introduction 
5.1.1 Progesterone Release from 
Reservoir Devices 
Since the pioneering work of Folkman and Long (108),who used 
silastic capsules to prolong drug therapy for heart blockage, many 
investigators have used reservoir type devices for sustained release 
drug delivery systems. 
Dziuk and Cook (109) observed that when si1astic tubes were 
filled with steroids and placed in a saline solution, the steroids 
were released from the tubes at a constant rate for several days. 
Similarly, Croxatto (110) found that when si1astic capsules contain-
ing a progestin were subdermal1y implanted in rates, pregnancy rates 
decreased. 
This early work (108) with silastic reservoir devices uti-
lized dry drug powder inside the core. Such devices do not provide 
a constant release rate of drug. This can be explained by the de-
creased surface contact of the drug with the polymer as the drug is 
depleted. Under the conditions of a constant effective surface area 
and a constant chemical activity of the drug, zero-order kinetics 
can be achieved. 
Most of the early work was performed using silastic rubber 
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since it can be easily molded into devices of various shapes and is 
nontoxic. Other polymers also have been tried. Alza developed the 
Progestasert™ 65 system which is made of an ethylene-vinyl acetate 
copolymer and delivers progesterone at a constant rate in utero for 
more than one year (111). Recent 1 y, Abraham and Rone 1 (112) used 
a hydrogel reservoir system for sustained zero-order release of 
narcotic antagonists. 
In this chapter progesterone release is described from hydro-
gel reservoir devices of cylindrical geometry in order to obtain 
additional input for contraceptive drug delivery systems. Zero-order 
release is possible with reservoir devices when the chemical activity 
of the drug and the diffusional surface area are maintained constant. 
For this purpose, the core of the device is filled with a biologically 
active agent suspended in a liquid which solubilizes the drug to some 
extent but does not penetrate the membrane composing the walls sur-
rounding the drug reservoir core. Silicone oil usually is used for 
this purpose. 
The release rate varies with geometry. For cylindrical geo-
metry the release rate of the drug from such devices is given as 




dt 1 n (ro/r;) 
(5-1 ) 
or 
dM t 2 TIhoPCw 
= 
(5-1-a) 
dt 1 n (r 01 r i ) 
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where ho ;s the length of the drug reservoir within the cylinder 
and ro and r i are the outer and inner radii of the cylinder, res-
pectively. Diffusion coefficients can be calculated using Equa-
tion 5-1. 







1 n (r olr i r (5-2) 
Once diffusion coefficients are obtained, release rates and 
the amount of drug released can be predicted from Equations 5-1 and 
5-2, respectively. However, for devices stored for a long time 
before use, a "burst effect, II in which the release rate is initially 
higher than the steady state rate, is expected. For devices freshly 
prepared, a IItime lag" effect, in which the release rate is initially 
less than the steady state value, is expected. 
Because the diffusion coefficient for a given membrane is 
constant regardless of geometry, diffusion coefficients obtained by 
any method can be used for the prediction of the steady state release 
rate. Once the diffusion coefficient is obtained, a desired amount 
of drug can be delivered by proper fabrication of devices where 
length, inner radius, and outer radius can be controlled. 
5.1.2 Release of Drug from Combined 
Type Devices 
Most of the recent designs of polymeric drug delivery systems 
belong to one of two types, namely the monolithic device type or the 
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reservoir device type. Each type of device has its ow~ advantages 
and disadvantages. 
The reservoir type device is preferred for most applications 
because it can provide a zero-order release rate which is an important 
factor for controlled release drug delivery systems. However, this 
type of device has problems related to the mechanical properties of 
the polymer. Depending' on the polymer material and wall thickness 
of the devices, there is the possibility of the rupture of the device. 
In the study of drug release from reservoir type devices composed of 
estriol core and polyurethane polymer, Baker et al. (115) pointed 
out that the device is too fragile below a certain thickness. Same 
problem of weak mechanical property is expected in case of hydrogel 
devices. If the device ruptures inside the body, too much drug will 
be released and the suspending agent will contact the biological 
tissues at the implant site, causing unexpected side effects. Usually, 
a highly potent drug is used for sustained release drug delivery sys-
tems so the tissues or the organ of the body where the device is 
implanted should be protected from exposure to large amounts of the 
drug. 
In the case of the monolithic device type, there is no danger 
of exposing too much drug or other agents to the implantation site 
of the body in the event of the device rupturing. But, as previous 
work (work in Chapter 4) has shown, the release rate of a drug from 
monolithic device follows a square root of time law and, therefore, 
the amount of drug released will decrease continuously with time. 
For this reason, monolithic devices cannot be used for long-term drug 
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delivery systems, especially when the difference between the toxic 
level and the therapeutic level, or therapeutic and nonactive level 
is small. 
However, if the major resistance to release of drug from a 
monolithic device occurs in the boundary diffusion layer, a zero-
order release rate can be obtained. Chien et al. (116,117) found that 
drug release from monolithic device followed a square root of time 
relationship when high drug solubility was maintained. As they de-
creased the drug solubility in the elution medium, zero-order release 
of drug was observed showing that the higher energy barrier outside 
of the device can be used to give zero-order release kinetics. In 
the same manner, other polymers which are less permeable to the drug 
can be used to give major resistance to the release of the drug. 
For these reasons, combined type devices were tried in this 
study. A combined type device is defined here as reservoir type de-
vice whose core is a dispersed monolithic device. Instead of a sus-
pending medium, the drug was dispersed in a polymer which constitutes 
the core of a plymer reservoir device. This combined type device is 
expected to give zero-order drug release and to cause no serious side 
effects in case of device rupture inside the body where the device is 
implanted. 
Equations which describe the release of drug from combined 
type devices were developed by Roseman and Higuchi (97). Initially, 
these equations were derived to explain aqueous boundary diffusion 
layers but should be applicable to the release of drug from combined 
type devices where aqueous boundary layer effects are neglected. 
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For the cylindrical geometry, the following equation can be 
obtained: 
( 1 - F) 1n (1 - F) + (1 + K') F = Kt (5-3) 
where 












r ': radius of core cylinder (cm) 
0 
rl = di stance from center of cylinder to receding drug 
boundary (cm) 
Cs 1 = drug solubility in core membrane 
Cs2 ': drug so 1 ubi 1 i ty in outside membrane 
01 ': diffusion coefficient of drug in core membrane 
°2 
': Diffusion coefficient of drug in outside membrane 
12 ': Thickness of outside membrane 
Equation (5-2) defines the fraction of drug release. The 
following equation describes the release rate: 
(5-4) 
where h is height of cylinder (cm), 
o 
Equation 5-3 shows that in a strict sense, the release 
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rate from a combined system cannot be constant (zero-order) because 
it will decrease as the F value increases. However, the combined 
type device is usually designed such that the decrease in release 
rate during several months is so small that it can be assumed con-
stant. 
5.2. Results and Discussion 
5.2.1 Drug Release from Reservoir 
Devices 
Figure 5-1 shows the progesterone release rate per day and 
total amount of drug released plotted versus time for a reservoir 
type device prepared from pHEMA. The release rate decreased con-
tinuously for 20 days and then became constant for the last experi-
mental period. Similar type of "burst effect lf was found for the re-
lease of progesterone from reservoir devices containing various poly-
mer compositions. In every case, the constant value of release rate 
was observed after certain time. 
Table 5.1 provides the permeability coefficients of pro-
gesterone from reservoir devices whose polymer capsules are composed 
of pHEMA, of pHEMA crosslinked with 2.3 mole percent EGDMA, and of 
copolymers of HEMA and MEMA. These values were obtained from the con-
stant release rate of each device, together with Equation 5-5. 
Equation 5-5 is obtained from Equation 5-la by rearrangement. 
p = 





























































Figure 5.1. Plots of total progesterone released and progesterone released per day versus time 
for a reservoir type device. 
w 
Table 5.1. Release Characteristics for Progesterone from Reservoir-Type Hydrogel Devices. 
Length Thickness 
Po l~mer (cm) mm 
HEMA 2.85 1 . 18 + .01 
HEMA + 2.3% EGDMA 1 .80 0.93+0.1 
MEMA-HEMA (1:2) 3.20 0.16+0.1 
t~EMA-HEMA (1: 4 ) 2.70 1 .02 + 0.1 
*Obtained from release studies. 
+Obtained fran melnbrane permeation studies (85). 
++ Data taken from Table 3.1. 
bility* 
x 10-7 









Because ro' r i , and hocan be obtained by measuring the di-
mensions of the reservoir device, the permeability can be calculated 
from the release rate provided that the drug solubility in water, 
C , is known. A value of 38 ugm/ml was utilized based upon the 
w 
average value obtained from the three methods described in Section 
2.2.2.1, 
The permeability coefficients obtained from the release 
studies of progesterone from reservoir devices were in good agreement 
with those obtained from membrane permeation studies where the hydro-
gel is in contact only with water. From these results, the following 
may be concluded. 
1. The presence of silicone oil in the reservoir does 
not affect the steroid permeability in the membrane and, 
therefore, does not significantly affect the equilibrium 
water content of the hydrogel membrane. 
2. The silicone oil maintains the chemical activity 
of progesterone in the core constant. 
3. The solubility of progesterone in water is close 
to 38 ugm/ml and the solubility measurement methods used in 
this study (2.2.2.1) can be used for other sparingly sol-
ub1e steroids. 
4. The solubility of slightly soluble solutes in 
aqueous solution can be calculated by the combination of 
permeation data from reservoir device with that from 
cross membrane experiment (2.2.1) using the same polymer. 
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Permeation parameters for progesterone transport through 
polymers in reservoir devices are shown in Table 5.2. From the 
diffusion coefficients and water fraction data, it can be concluded 
that the diffusion coefficient increases as the equilibrium water 
content of polymer increases for th~se polymers. Data in Table 5.2 
shows that other factors besides the equilibrium water content affect 
the diffusion coefficient. If water content is the only factor, the 
diffusion coefficient of progesterone in a HEMA-MEMA (4:1) copolymer 
should less than that in pHEMA with 2.3 mole percent of EGDMA since 
the water content of the former is less than that of later. Accord-
ing to the data given in Table 5.2, the permeabilities of hydrogels 
depend upon the water content and/or the nature and concentration of 
the crosslinker. It can be concluded that desired constant release 
rate can be obtained by choosing proper polymer composition. 
5.2.2 Drug Release from Combined 
Devices 
Progesterone release from combined devices prepared with an 
outer membrane prepared from pHEr~ were studied. An inner core 
matrix was made from either MEEMA or a HEMA-MEE~A copolymer in which 
progesterone is dispersed or dissolved. Figure 5.2 is a plot of 
the fraction of drug released from the combined devices as a function 
of time, comparing experimentally determined data (solid lines) to 
the theoretically expected values (dashed line) as determined by 
Equation 5-3, together with necessary data obtained through the 
1 i tera ture. 
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Table 5.2. Permeation Parmaters of Progesterone Transport in 
Reservoir Devices. 
P x 107(cm2/sec) K D x 109(cm2/sec) Wf 
HEMA 10.7 139 7.70 0.41 
HEMA + 2.3% EGDMA 2.32 151 1 .54 0.38 
~1EMA-HEMA (1 : 2) 2.76 192 1.44 0.31 
MEMA-HEMA (1 : 4 ) 3.08 156 1 .97 0.34 
MEEMA-HEMA core / / 0 .I' 
W 0.15 HEMA coating p (J) ,;-
« MEEMA core / / W ; 
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In both experimental cases, the release rate of progesterone 
per day becomes constant after 20 days. For the device prepared with 
HEMA-MEEMA copolymer core and pHEMA coating, the positive deviation 
of early time from the calculated value is probably due to the 
"burst" effect. However, the early time negative deviation in device 
with pMEEMA core cannot be explained clearly. The observed and pre-
dicted release rate together with the dimensions of the devices are 
given in Table 5.3. The predicted release rates were obtained by 
using Equation 5-4. Because less than 15% of the drug was released 
during the experiment, a value of 0.1 was used for F (fraction of drug 
released). The change in the predicted release rate arising from 
the change of F value from 0 to 0.1 was less than 5%. 
In both cases, experimental values were smaller than predicted 
values. Rather small difference between the observed and predicted 
release rate was obtained for the device with a HEMA-MEEMA copolymer 
core. Large differences were obtained with the device having pMEE~~ 
core. This may be explained by a II res tricted water swelling" of core 
polymer due to the outer coating polymer. The swelling capacity of 
outer coating material (pHEMA) is less than that of core material 
(pMEEMA or copolymer of HEMA and MEEMA). Because of the less effec-
tive swelling of outside polymer, the core polymer will receive pres-
sure resisting the expansion of core polymer which is the result of 
swelling. Thus, restricted water swelling will result in reduced 
water up~ake which in turn will decrease progesterone permeability in 
the polymer. This "restricted water swelling" effect is more pre-
dominant in polymer which has high equilibrium water content. The 
e 5.3. Release Characteristics for Progesterone from Combined Type Hydrogel Devices. 
Monolithic Core 
67 percent MEEMA + 




eoa t i ng 
Ttli ckness 
Coa ti ng (em) 
HEMA 0.103 + 0.01 
HEMA 0.103 + 0.01 
Core Release 
Radius Length Rate 
(em) (em) (11gm/day) 
.160 3.37 74.7* 88.1 + 




larger negative deviation of the experimental value in combined 
device with pMEEMA whose equilibrium water content is greater than 
that of copolymer of HEMA and MEEMA can be explained by this II res trict 
wa ter swe 11 i ng . II 
From this study of drug release from the combined device, it 
can be concluded: 
1. Pseudo zero-order release rate can be achieved for 
months from combined devices. 
2. In case of combined device whose core is composed 
of a hydrogel, experimental release rates are smaller than 
predicted due to 'restricted water swelling effect. I 
3. For combined devices whose core is composed of hydro-
gel, further refinements in the preparation method is re-
quired, for practical application. 
Chapter 6 
SOLUTE PERMEATION IN HYDROGEL FILMS: AN 
IRREVERSIBLE THERMODYNAMIC APPROACH 
6.1. Introduction 
In classical transport studies solute permeation through 
membranes is described by two coefficients, namely the diffusion co-
efficient and the partition coefficient. It has already been men-
tioned that diffusion in a membrane comes from molecular motion which 
is a function of the kinetic energy of the molecule as well as of 
the frictional forces exerted on the molecules by the medium through 
which the dissolved molecules are moving. Thus, solute passage 
through a membrane involves three factors, namely, the friction be-
tween solute and membrane, the friction between solute and solvent, 
and the friction between solvent and membrane. A full description 
should be able to take account of these coefficients whose value will 
depend upon the nature of the three processes involved. As mentioned 
by Kedem and Katchalsky (118), the two coefficients obtained by 
classical methods are not sufficient for a complete description of 
the permeation phenomena through a membrane. 
In case of phenomenological theories based on irreversible 
thermodynamics, which were developed by Staverman (119-121) and 
extended by Kedem and Katchalsky (118, 122, 123) a membrane system 
where solute and solvent are present is described by means of three 
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characteristic quantities. These are the f11tration coefficient Lp, 
the reflection coefficient a of Staverman and the solute permeability 
coefficient wof Kedem and Katchalsky (118). The quantities wand 
a provide information about the relative selectivity of the membrane 
for a particular solute. 
For an ideal semipermeable membrane in which only the sol-
vent permeates, 0 = 1.0 and w = O. For membrances permeable to the 
solute a < 1 and w > 0 and a decrease as the selectivity of the 
membrane decreases. The quantity Lp provides a measure of the total 
flow of solute and solvent. The only drawback of these three coeffi-
cients is the fact that these coefficients refer to the system as a 
whole. Specific interactions are not taken into account by the analy-
sis. 
Such specific information can be obtained from the frictional 
coefficients. These coefficients result from the frictional model 
(124-127). In this model, it is assumed that at steady state, 
the driving force for diffusion is counterbalanced by the retarding 
frictional forces generated between molecules. These coefficients 
are fsw, fsm, and fwm. The coefficient fsw refers to the interaction 
between one mole of solute with the water found in the membrane; 
the coefficient fsm refers to the interaction of one mole of solute 
with the membrane matrix; and the coefficient fwm describes the in-
teraction of one mole of water and the membrane matrix. ihese fric-
tional coefficients can be evaluated from the three experimental 
quantities 0, Lp, and w. When the membrane is chemically inert, 
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information is gained about its geometry by comparing the friction 
between solute and solvent in free solution to the friction between 
the same components in the membrane. 
If for a given membrane, with regard to a number of different 
solutes but always with the same solvent, these frictional coeffi-
cients are equal except for a constant factor, then this is a strong 
indication that only geometrical effects are involved (128). In 
this case, a purely geometrical character can be ascribed to the co-
efficients, such as the porosity and the tortuosity of the membrane. 
It is also possible to make a clearer distinction between the "pore 
mechanism," and the "partition mechanism'! models by comparing fric-
tional coefficients. 
It is apparent, therefore, that the irreversible thermo-
dynamic approach provides information which reflects both the selec-
tivity of the membrane as well as the nature of the interaction be-
tween the solute, solvent, and membrane. This information is diffi-
cult to develop from the more classical approach based upon measure-
ments of diffusion coefficients. 
In this chapter, the permeation of a solute is examined based 
upon the irreversible thermodynamic approach. The polymer films 
examined were prepared from hydroxyethyl methacrylate, both with and 
without the crosslinker, ethyleneglycol dimethacrylate. Because of 
the low water solubility of the hydrophobic steroids, which makes the 
experiment quite difficult, water soluble solutes such as urea and 
sucrose were used. These results provide valuable information about 
the nature of the permeation process and can be useful in the 
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development of these membranes for applications in controlled release 
drug delivery systems and in the artificial kidney. 
The permeation parameters, Lp, 0, and w can be obtained ex-
perimentally from measurements of the volume flow, Jv, and from the 
solute flow, Js, under differing pressures. The pressure difference 
is produced either via a hydrostatic pressure (~P) or via osmotic 
pressure (6rr). Under a condition in which a hydrostatic pressure 
is applied to the compartment lower in concentration, the volume 
flow across a semi-permeable membrane is defined by: 
= Lp U~P + a (6-1 ) 
\~here the effective osmotic pressure (lriT
o
) is given by 0~1T, and 6.II
o 
is the ideal (van't Hoff) value. The total solute flow under the 
condition in which the volume flow is zero is given by: 
Js = wLl'IT (6-2) 






where 1 is the 
(Jv - Lp 6P) 
Lp 6 0 
(J 5 ) J v = 0 
(DKd) J v = 







In general, the total frictional coefficient of one mole of given 
molecule with a system (ft ) can be expressed as: 
.(: = RT 
It 0 (6-6) 
The three frictional coefficients, fsw, fsm, fwm, necessary to des-
cribe solute-water-membrane system can be defined in terms of the 
phenomenological coefficients as follows: 
-
wV 2.Y fsw = ( 1 _o __ s) Lp lw (6-7 ) 
-
[( ~d _ wV fsm = ( 1 
- Cf _2)J w qJV Lp (6-8) 
-
¢V VW -fwm = Vw Cs ( 1 - 0) fsm lLp (6-9) 
where 
rpV = Water content of membrane in terms of volume fractions 
-Vw = Partial molar volume of water 
-Vs = Partial mol ar volume of solute 
Cs = Average solute concentration in the membrane. 
6.2. Results and Discussion 
Table 6.1 shows the results obtained for the phenomenologi-
cal coefficients for the hydrophilic solutes in a hydrogel membrane. 
Urea, glucose, and sucrose are 'used as solutes while pHEMA and pHEMA 
crosslinked with one mole percent EGDMA are used as membranes. Since 
Table 6.1. Phenomenological Coefficients, Water Contents, and Partition Coefficients for 
Urea, Glucose, and Sucrose in Various Membranes. 
Lp x d w x d 
¢v 
mo1e-cm 
Kd Membrane Solute cm4/d,r:ne-sec 0 dyne-sec 
pHEMAa Urea .526 8.56 x 10- 15 0.0718 3.08 x 10-17 0.53 
ucose .475 6.75 x 10- 15 0.752 2.43 x 10- 18 0.23 
Sucrose .470 5.95 x 10- 15 0.940 4.64 x 10-19 0.23 
pHEMA + 1 Urea .525 6.34 x 10- 15 0.0632 2.50 x 10- 17 0.48 
mole % Glucose 3.05 x 10- 15 1.52 x 10- 18 0.24 EGDMA a 
Sucrose 3.58 x 10-19 0.25 
Cupraphane b Urea .676 1 . 084 x 1 0 - 1 3 0.026 1.07 x 10- 16 0.54 
Glucose .676 9.09 x 10- 14 0.088 2.41 x 10- 17 0.29 
Sucrose .676 7.74 x 10- 14 0.174 1.72 x 10-17 0.30 
Cellophanec Urea 
Glucose .694 1.70 x 10- 13 0.0885 3.39 x 10- 17 0.704 
Sucrose .694 1.62 x 10- 13 0.105 2.12 x 10-17 0.734 
Wet Gel d Urea .77 8.21 x 10- 13 0.0016 2.66 x 10- 16 
Glucose .77 8.21 x 10- 13 0.024 9.51 x 10- 17 
Sucrose .77 8.21 x 10-13 0.036 6.44 x 10- 17 
a!1c ::: 0.15 M from Re f. ( 76) 6 c = O. 05 M 
cdata from Ref. (129) 6c ::: 0.05 M ddata from Ref. (128) 6c 1.0 M N "'-J 
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Lp and ware both dependent upon the membrane thickness, the normal-
ized values, Lp x 1 and w x 1, are used in Table 6.1. The reflec-
tion coefficient, 0, is independent of the membrane thickness. 
The filtration coefficient (normalized for thickness) is a 
measure of the total volume flow per unit thickness in a membrane. 
From Table 6.1, we see that the filtration coefficient for a given 
membrane decreases as the solute size increases. This result is 
consistent with a blockage or clogging of some of the pores or chan-
nels through which solvent and solute molecules pass in a hydrogel 
membrane. Based upon this interpretation, it is expected that Lp x 
should be dependent upon solute concentration. Furthermore, Lp x 
should reach a limiting value, independent of solute size, in very 
dilute solution. These expectations, have been experimentally veri-
fied for cellophane membranes by Kaufmann and Leonard (129). 
Table 6.1 also shows literature data of the phenomenologi-
cal coefficients for urea, glucose, and sucrose in cellulosic based 
hydrogel membrances. From this table, it can be seen that the filtra-
tion coefficient increases as the water content of the membrane in-
creases for a given solute. The magnitude of change in Lp x 1 with 
water content is much greater than the solute size effect discussed 
above. For example, Lp x 1 in pHEMA changes by a factor of about 
15 4 -15 4 1.5 (5.95 x 10- cm /dyne-sec to 8.56 x 10 cm /dyne-sec) when 
the solute is changed from sucrose to urea. In contrast, Lp x 1 
increases by more than a factor of 100 when the water content is 
increased from about 0.47 (pHEMA) to 0.77 (wet gel). Lp x 1 for 
cuprophane and cellophane are intermediate between these extremes. 
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Nonetheless, it is apparent that pHEMA is a much less permeable mem-
brane than any of the cellulosic based films. The restrictive nature 
of pHEMA is enhanced by the incorporation of one mole percent EGDMA 
(Table 6.1). 
The solute permeability coefficient, W, of Kedem and Katchal-
sky is directly related to the classical diffusion coefficient, D, 
obtained from Fick's Law. From Equation 6-5, 'it can be seen that 
w is inversely proportional to membrane thickness and directly pro-
portional to the diffusion coefficient. In a sense, w, normalized 
for thickness (w x 1) can be viewed in the same way as the classical 
diffusion coefficient D. Data in Table 6.1 shows that w x 1 for 
a given solute in the various membranes increases as the water content 
of a membrane increases. Table 6.1 also shows that for a given 
membrane w x 1 decreases with an increase in solute size. In general, 
the scale of the decrease in the solute permeability (w x 1), with 
solute size is larger with a hydrogel having a relatively small water 
content. These findings from solute permeability data are consistent 
with the hypothesis that hydrophilic solutes such as urea, glucose, 
and sucrose transport a hydrogel membrane primarily by a pore mechan-
ism (59). 
The reflection coefficient a is a measure of the relative 
degree of selectivity of the membrane between solute and solvent. 
If a hydrophilic solute permeates via pores or micro channels present 
in the hydrogel membrane, selectivity for a given solute should de-
crease as the water content or pore size increases. The reflection 
coefficient data in Table 6.1 demonstrate this trend. The low 
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se1:ectivity for a solute in a cellulosic membrane indicates re1a-
tive1y large pore size compared with the solute size. The large 
value of this coefficient for glucose or sucrose in a pHEMA membrane 
shows that the pore size of pHEMA hydrogels is approximately equal 
to or slightly larger than the size of the solute. It can be said 
that sucrose is almost totally reflected relative to water while 
urea and water permeate pHEMA membrane at very similar rates. 
From Table 6.1, it can be seen that the a value for urea 
in pHEMA is greater than that of pHEMA which has been crosslinked 
with EGDMA. This can be interpreted to imply that a crosslinked 
pHEMA membrane is less selective toward urea. An opposite result is 
expected if the solute is thought to permeate in the hydrogel by a 
pore mechanism. The selectivity of a crosslinked pHEMA should in-
crease since a crosslinked pHEMA is thought to have a smaller pore 
size than noncrosslinked pHEMA. Considering the fact that the total 
permeability of both solute and solvent decrease as the pHEMA mem-
brane is crosslinked, it can be concluded that the contribution of a 
partition mechanism in urea permeation through hydrogel membrane 
cannot be neglected. Further comment about this point will be pro-
vided from frictional coefficient data. 
In very dilute solution, fwm for a single membrane should 
be the same as that of a pure water-membrane system regardless of 




::: 1 x Lpb (6- 1 0) 
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where Lpb is the filtration coefficient of a pure water - membrane 
system. This fact was confirmed by the work of Kaufmann and Leonard 
(129). 
From the relationship between Lp x 1 and the water content, 
together with Equation 6-9, it is expected that fwm should increase 
with decreases in water content. Table 6.2 shows that the depen-
dence of fwm on the ~/ater content is as predicted. The data for the 
pHEMA and pHEMA crosslinked with EGDMA indicates that the pore size 
of the crosslinked pHEMA is smaller than that of noncrosslinked 
pHEMA. The smaller pore size causes a larger clogging effect for 
the same solute resulting in a greater interaction between the sol-
vent and the membrane. The dependence of the solute clogging effect 
on the pore size of a membrane is expected to be greater for a larger 
solute molecule. This point can be verified by the fwm values of 
solutes on pHEMA and crosslinked pHEMA. Table 6.2 shows that fwm 
for urea increases 1.2 times as the membrane changes from pHEMA to 
crosslinked pHEMA while fwm for glucose increases 2.2 times for the 
same membrane change. 
As mentioned earlier, fsw provides a measure of collisional 
i nteracti ons between so 1 ute an d wa ter ina membrane. It is expected 
that fsw would be closely related to fsw o which is the frictional 
coefficient between solute and water in an aqueous solution. fsw o 




where D° is the diffusion coefficient of a solute in water.· For an 
ideal porous-type membrane, like a· glass filter, as the pore size 
of the membrane increases, both a and w/Lp approach O. This trend 
can be demonstrated by the data in Table 6.1. Name1Ya for urea 
changes from 0.713 for pHEMA to 0.0016 for wet gel and w/Lp for the 
same solute changes from 3.6 x 10- 3 mo1e/cm3 for pHEMA to 3.2 x 10-4 
mole/cm3 for wet gel. Therefore, Equation 6-7 can be approximated 
as follows: 
fsw = l6-12) 
In order to relate fsw to the diffusion coefficient, Equation 6-5 
can be combined with Equation 6-12 to yield 
fsw = ¢w RT Dkd (6-13) 
Equation 6-14 and Equation 6-11 are very similar. In the extreme 
case of a large pore size membrane, such as a glass filter, Kd be-
comes ¢w and 0 approaches D°. In this case, fsw approaches fswo, As 
shown in Table 6.2, the values of fsw of wet gel are quite close 
to the fsw o for the same solute. Thus, fsw also demonstrates that 
the wet gel behaves as a membrane with large pores and that the in-
teraction between the solute and water is not very different from 
that obtained in pure water. As the pore size of the membrane de-
creases or as water content decreases, a considerable increase in 
the solute-water interaction occurs. As noted~ fwm also increases 
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Table 6.2. Frictional Coefficients for Urea, Glucose, and Sucrose 
in pHEMA and Cellulosic Membranes. 
Coefficient Membrane Urea Glucose Sucrose 
fsw 
dyne-sec x 10- 16 pHEMA 1 .31 4.06 4.42 
mole-em pHEMA + EGDMA 1 .60 
Cupraphane 0.60 2.47 3.06 
Cellophane 1 .81 2.82 
Wet Gel 0.282 0.78 1 . 13 
fsm 
dyne/sec x 10- 16 pHEMA 0.408 5.41 45.2 
mole/em pHEMA + EGDMA 0.319 
Cupraphane -0.086 -1 .25 -1 .30 
Cellophane 0.250 0.617 
Wet Gel 0.0046 0.030 0.067 
fwm 
dyne-sec x 10- 13 pHEMA 111 127 142 
mole/em pHEMA + EGDMA 129 281 
Cupraphane 11 .4 14.5 16.4 
Cellophane 8.30 8.55 
Wet Gel 1 .68 1 . 71 1 .74 
fws/fsm pHEMA 3.22 0.750 0.0976 pHEMA + EGDMA 5.03 
Cupraphane -6.8 -2.0 -2.4 
Cellophane 7.24 4.6 
Wet Gel 61 .0 26.0 16.8 





a) Values calculated using Equation 6-12 and the diffusion coeffi-
cient data obtained from reference (59). 
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under the same conditions. Thus, frictional interactions between 
water and membrane appear to be translated into an increased fric-
tiona1 interaction between the solute and water. 
1'\ 
As mentioned earlier, fs~ provides a measure of interaction 
between the solute and the membra'ne. The role of this interaction 
on solute permeation in a hydrogel membrane can be understood by the 
modification of Equation 6-9. This equation can be changed as 
follows: 
fsm = 1: [ Kd ¢v (1 - cr - w Vs ) ] Lp 
-
= 
Kd ¢v (1 _ a _ wVs 
w - TW Lp 
Incorporation of Equations 6-5 and 6-7 to Equation 6-15 gives 
fsm RT = 0- fsw 
(6-14) 
(6-15) 
The first term on the right side of Equation 6-16 can be termed, 
the total frictional coefficient (ftss) of a solute in a membrane-
water-solute system so that Equation 6-16 can be rewritten as: 
fsm + fsw RT = = o ftss (6-16) 
Equation 6-17 shows that it is the summation of fsm and fsw rather 
than fsm which is inversely proportional to the diffusion coeffi-
cient. However, data in Table 6.2 shows that fsm changes more 
dramatically than fsw with a change of the diffusion coefficient 
For example, fsw for pHEMA increases by four times as the solute 
changes from urea to glucose while fsm for pHEMA increases by 17 
times for the same change of solute. 
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For a porous-type membrane whose pore size is much greater 
than the size of the solute, the solute will interact primarily with 
the water molecules present in the pores. The interaction of the 
solute with the membrane, which acts as the wall of a water-filled 
pore, is negligibly small when compared to the interaction between the 
solute and the water molecules. For a given solute, as the pore size 
of the membrane decreases the contribution of fsm to the total inter-
action between the solute and the system increases. 
cularly evident from the ratio fsw/fsm (Table 6.2). 
This is parti-
This ratio de-
creases both with solute size in given membrane and with the same 
solute in the various membranes. 
It was noted from the analysis of the values that there should 
be some contribution of the partition mechanism to the total transport 
of urea in the pHEMA membranes. A similar conclusion is evident also 
from an analysis of fsm. For example, if porous transport dominates 
the flow of this solute, then fsm should increase with crosslinking 
due to the decrease in pore size. In fact, the opposite trend is 
observed (Table 6.2). 
In order to rationalize this result, the following model for 
urea transport in pHEMA is proposed. This model is presented in 
Figure 6.1. In this model, it is assumed that transport of urea 
occurs via both the pore mechanism and the partition mechanism in 
HEMA i % X - lin k e r 
~ I Membrane I . Membrane ~'--'---------------L-~~-·20 
t-----.I \ I ). 2 5 
w :; 100 






...J ;; 90 
R :; 0.011 
Lp:; 8,590 








both membrane~. Water transport is assumed to occur mainly by a 
pore mechanism based on the fact that the fwm increases as the mem-
brane changes from a pHEMA to a crosslinked pHEMA system. 
In this model, it was assumed that 20 percent and 28 percent 
of the total urea transport occurs via the partition mechanism in 
pHEMA and in crosslinked pHEMA, respectively. The numbers of solute 
molecules permeating by the partition mechanism and by the pore 
mechanism, together with the number of permeating solvent molecules 
in both membranes~ were arbitrarily assumed as shown in Figure 6.1. 
The solute permeability , is proportional to the diffusion coeffi-
cient and should be proportional to the total number of solute mole-
cules permeating the membrane. Therefore, an arbitrary number of 
100 and of 90 was assigned for pHEMA and crosslinked pHEMA, respec-
tively. The filtration coefficient Lp should be directly related to 
the total volume flow across the membrane. Since the contribution of 
the solute flow to the total volume flow is very small, the numbers 
of both molecules were arbitrarily used as the Lp value as shown in 
gure 6.1. The relative rate of solute transport (R) is defined 
as: 
R = Ns Nw (6-19) 
Where Ns is the number of solute molecules permeating the membrane 
and Nw is the number of solvent molecules permeating the same mem-
brane. According to this definition, 0.010 and 0.011 can be assigned 
for each membrane. It is obvious that R should increase as the 
selectivity of the membrane or cr decreases. 
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In order for the model to be valid, the results of the cal-
culations made using the described model shou1~ be consistant with 
the experimental values. This consistancy is tested by the follow-
ing facts: 
1. The Lp x 1 and w x 1 values for a pHEMA membrane 
are greater than those of a crosslinked pHEMA membrane, 
both in experimental and model cases. 
2. In the experimental case the a value decreases as 
the membrane changes from pHEMA to crosslinked pHEMA, 
while in the model case, the R value increases with the 
same membrane changes. Considering the fact that R should 
increase as a decreases, the same trend is observed both 
experimentally and in the model case. 
3. Experimentally, fwm increases as the membrane 
changes from'pHEMA to crosslinked pHEMA. This indicates 
that the number of solvent molecules permeating through 
the membrane will decreases, which is consistent with the 
model. 
4. Experimentally fsm decreases as the membrane 
changes from pHEMA to crosslinked pHEMA. This predicts 
that the number of solute molecules permeating by a 
partition mechanism will increase, which is also con-
sistant with the model. 
5. Experimentally fsw increases as the membrane is 
changed from pHEMA to a crosslinked pHEMA, indicating that 
the number of solute molecules permeating the membrane 
by the pore mechanism will decrease consistent with the 
model theory. 
6. Experimentally, fsw/fsm increases as the membrane 
is crosslinked indicating that partition character in a 
solute permeation mechanism will increase. The increase 
of partition mechanism from 20 percent to 28 percent at 
the membrane change of the model is constant with the ex-
perimental results. 
All these agreements between the experimental values and 
those obtained in the model treatment show that this model can be 
used to describe this system. 
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Chapter 7 
SUMMARY AND CONCLUSIONS 
This dissertation describes investigations of factors which 
affect permeation of progesterone through hydrogel polymers. 
The investigations were performed to provide data necessary for the 
design of a controlled release drug delivery systems. Such systems 
are designed to deliver an optimum amount of drug at a constant rate 
for extended periods. Progesterone was used as a model drug. Hy-
droge1s made from momomers such as HEMA, MEEMA, MEMA, and MMA were 
used as the polymers for the system. The rationale for the use of 
these hydroge1s was discussed in Chapter 1. 
In general, the permeation rate of drug in a membrane fol-
lows Fick's law: the rate of drug diffusion depends on six factors. 
These are surface area (A), thickness of the membrane (1), the 
equilibrium solubility of drug in the polymer (C s )' the partition 
coefficient (Kd), the diffusivity of a drug in a polymer (0), and the 
permeabi1ity of a drug in a polymer (P). 
The values of CS,Kd,D and P of the drug can be varied by the 
combination of monomers and methods of preparation. The release 
kinetics can be varied by changing the thickness and area of the 
devices over time. 
In Chapter 3 permeation parameters such as Cs, Kd, and P of 
several solutes in various hydroge1s were discussed. The effects of 
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equilibrium water content, initiator, crosslinker, and functional 
groups were studied. A new equation for transport studies in 
polymeric films, where partition coefficients are large, was derived 
and compared with results obtained from previous equations. From 
these studies the following conclusions were made: 
1. The permeability coefficients of progesterone in pHEMA 
membrane decrease as the initiator concentration increases, however, 
this effect is rather small. 
2. The permeability coefficient of estriol in pHEt1A cross-
linked with EGDMA, decreases as the amount of crosslinker increase. 
This may be due to the decreased pore size. 
3. In general, solute transport in hydrogel membrane occurs 
through fluctuating pores present in the gel, and the permeability 
coefficients increase as the equil ibrium water content increases. 
In Chapter 4, progesterone releases from monolithic 
devices was studied. A new equation was developed in order to des-
cribe drug release from cylindrical devices which have various ratios 
of radius to height. In this equation, it is assumed that drug re-
lease from the edges and lateral surfaces follows that of planar and 
long cylinder geometry respectively. Excellent agreement was 
observed between calculated data using this equation and experiment-
al data obtained on progesterone release from silastic rubber de-
vices. 
The progesterone release from monolithic hydrogel devices 
was investigated using homopolymers and copolymers of MEMA, MEEMA, 
and HEMA. The following is a summary of the results. 
1. Progesterone release from monolithic devices follows 
first order kinetics. 
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2. In the case of progesterone release from initially dry 
devices, water influx into the device affects the release rate of 
the drug from the device. 
3. Initial drug loading affects the permeability of the drug 
in the polymer. 
4. By comparing permeability data obtained from cross-
membrane studies and from matrix release studies~ aqueous solu-
bility of sparingly soluble solute can be obtained. 
In Chapter 5, progesterone release from reservoir and com-
bined type devices with cylindrical geometry was investigated. 
Zero-order release rates were observed in both reservoir and combined 
type devices. The observed release rates were compared with the 
values calculated from data in the literature. Excellent agreement 
is found in the case of the reservoir devices. The results discussed 
in Chapter 5 indicate: 
1. Silicone oil acts as a suspending medium and maintains 
the activity of progesterone constant in reservoir devices. 
2. In the case of combined type devices the outer mem-
brane, which swells less than the core polymer, restricted the swell-
ing of the inner polymer. The restricted swelling reduces the drug 
release rate from these devices compared with the predicted values. 
In Chapter 6, an irreversible thermodynamic approach to 
solute permeation through membranes has been used in order to per-
form an in depth study of solute transport phenomena in hydrogels. 
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The permeation of sucrose, glucose, and urea through pHEMA membranes 
both with and without EGDMA crosslinker was studied. The results 
indicate that, in general, permeation of water soluble solutes in 
these films is dominated by a pore mechanism. However, in the case 
of urea, solute-membrane interactions contribute to the total per-
meability of this solute. 
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